<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1 20151215//EN"  "JATS-archivearticle1.dtd"><article article-type="research-article" dtd-version="1.1" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xlink="http://www.w3.org/1999/xlink"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn pub-type="epub" publication-format="electronic">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">59809</article-id><article-id pub-id-type="doi">10.7554/eLife.59809</article-id><article-categories><subj-group subj-group-type="display-channel"><subject>Research Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Cancer Biology</subject></subj-group></article-categories><title-group><article-title>Methionine restriction breaks obligatory coupling of cell proliferation and death by an oncogene Src in <italic>Drosophila</italic></article-title></title-group><contrib-group><contrib contrib-type="author" id="author-192825"><name><surname>Nishida</surname><given-names>Hiroshi</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0003-0284-5771</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="con1"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" equal-contrib="yes" id="author-192826"><name><surname>Okada</surname><given-names>Morihiro</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="fn" rid="equal-contrib1">†</xref><xref ref-type="fn" rid="con2"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" equal-contrib="yes" id="author-192827"><name><surname>Yang</surname><given-names>Lynna</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="equal-contrib1">†</xref><xref ref-type="fn" rid="con3"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-224631"><name><surname>Takano</surname><given-names>Tomomi</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="fn" rid="con4"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-192828"><name><surname>Tabata</surname><given-names>Sho</given-names></name><xref ref-type="aff" rid="aff4">4</xref><xref ref-type="fn" rid="con5"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-2002"><name><surname>Soga</surname><given-names>Tomoyoshi</given-names></name><xref ref-type="aff" rid="aff4">4</xref><xref ref-type="fn" rid="con6"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-23225"><name><surname>Ho</surname><given-names>Diana M</given-names></name><xref ref-type="aff" rid="aff5">5</xref><xref ref-type="fn" rid="con7"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-48905"><name><surname>Chung</surname><given-names>Jongkyeong</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">http://orcid.org/0000-0001-5894-7537</contrib-id><xref ref-type="aff" rid="aff6">6</xref><xref ref-type="other" rid="fund3"/><xref ref-type="fn" rid="con8"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-192829"><name><surname>Minami</surname><given-names>Yasuhiro</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con9"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes" id="author-146334"><name><surname>Yoo</surname><given-names>Sa Kan</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0003-3358-4818</contrib-id><email>sakan.yoo@riken.jp</email><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="aff" rid="aff7">7</xref><xref ref-type="other" rid="fund1"/><xref ref-type="other" rid="fund2"/><xref ref-type="fn" rid="con10"/><xref ref-type="fn" rid="conf1"/></contrib><aff id="aff1"><label>1</label><institution>Division of Cell Physiology, Kobe University</institution><addr-line><named-content content-type="city">Kobe</named-content></addr-line><country>Japan</country></aff><aff id="aff2"><label>2</label><institution>RIKEN CPR</institution><addr-line><named-content content-type="city">Kobe</named-content></addr-line><country>Japan</country></aff><aff id="aff3"><label>3</label><institution>RIKEN BDR</institution><addr-line><named-content content-type="city">Kobe</named-content></addr-line><country>Japan</country></aff><aff id="aff4"><label>4</label><institution>Institute for Advanced Biosciences, Keio University</institution><addr-line><named-content content-type="city">Tsuruoka</named-content></addr-line><country>Japan</country></aff><aff id="aff5"><label>5</label><institution>Harvard Medical School</institution><addr-line><named-content content-type="city">Boston</named-content></addr-line><country>United States</country></aff><aff id="aff6"><label>6</label><institution>Seoul National University</institution><addr-line><named-content content-type="city">Seoul</named-content></addr-line><country>Republic of Korea</country></aff><aff id="aff7"><label>7</label><institution>Division of Developmental Biology and Regenerative Medicine, Kobe University</institution><addr-line><named-content content-type="city">Kobe</named-content></addr-line><country>Japan</country></aff></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor"><name><surname>Banerjee</surname><given-names>Utpal</given-names></name><role>Reviewing Editor</role><aff><institution>University of California, Los Angeles</institution><country>United States</country></aff></contrib><contrib contrib-type="senior_editor"><name><surname>Banerjee</surname><given-names>Utpal</given-names></name><role>Senior Editor</role><aff><institution>University of California, Los Angeles</institution><country>United States</country></aff></contrib></contrib-group><author-notes><fn fn-type="con" id="equal-contrib1"><label>†</label><p>These authors contributed equally to this work</p></fn></author-notes><pub-date date-type="publication" publication-format="electronic"><day>27</day><month>04</month><year>2021</year></pub-date><pub-date pub-type="collection"><year>2021</year></pub-date><volume>10</volume><elocation-id>e59809</elocation-id><history><date date-type="received" iso-8601-date="2020-06-09"><day>09</day><month>06</month><year>2020</year></date><date date-type="accepted" iso-8601-date="2021-04-02"><day>02</day><month>04</month><year>2021</year></date></history><permissions><copyright-statement>© 2021, Nishida et al</copyright-statement><copyright-year>2021</copyright-year><copyright-holder>Nishida et al</copyright-holder><ali:free_to_read/><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><ali:license_ref>http://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="elife-59809-v1.pdf"/><abstract><p>Oncogenes often promote cell death as well as proliferation. How oncogenes drive these diametrically opposed phenomena remains to be solved. A key question is whether cell death occurs as a response to aberrant proliferation signals or through a proliferation-independent mechanism. Here, we reveal that Src, the first identified oncogene, simultaneously drives cell proliferation and death in an obligatorily coupled manner through parallel MAPK pathways. The two MAPK pathways diverge from a lynchpin protein Slpr. A MAPK p38 drives proliferation whereas another MAPK JNK drives apoptosis independently of proliferation signals. Src-p38-induced proliferation is regulated by methionine-mediated Tor signaling. Reduction of dietary methionine uncouples the obligatory coupling of cell proliferation and death, suppressing tumorigenesis and tumor-induced lethality. Our findings provide an insight into how cells evolved to have a fail-safe mechanism that thwarts tumorigenesis by the oncogene Src. We also exemplify a diet-based approach to circumvent oncogenesis by exploiting the fail-safe mechanism.</p></abstract><kwd-group kwd-group-type="author-keywords"><kwd>oncogene</kwd><kwd>nutrition</kwd><kwd>cell death</kwd><kwd>proliferation</kwd><kwd>methionine</kwd></kwd-group><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd><italic>D. melanogaster</italic></kwd></kwd-group><funding-group><award-group id="fund1"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100001691</institution-id><institution>Japan Society for the Promotion of Science</institution></institution-wrap></funding-source><award-id>JP16H0622</award-id><principal-award-recipient><name><surname>Yoo</surname><given-names>Sa Kan</given-names></name></principal-award-recipient></award-group><award-group id="fund2"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100009619</institution-id><institution>Japan Agency for Medical Research and Development</institution></institution-wrap></funding-source><award-id>17939907</award-id><principal-award-recipient><name><surname>Yoo</surname><given-names>Sa Kan</given-names></name></principal-award-recipient></award-group><award-group id="fund3"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100003725</institution-id><institution>National Research Foundation of Korea</institution></institution-wrap></funding-source><award-id>NRF-2020R1A5A1018081</award-id><principal-award-recipient><name><surname>Chung</surname><given-names>Jongkyeong</given-names></name></principal-award-recipient></award-group><funding-statement>The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.</funding-statement></funding-group><custom-meta-group><custom-meta specific-use="meta-only"><meta-name>Author impact statement</meta-name><meta-value>Src, an oncogene, promotes both cell proliferation and cell death simultaneously, which can be regulated by dietary methionine.</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="s1" sec-type="intro"><title>Introduction</title><p>Tumorigenesis requires activation and inactivation of not one, but multiple signaling pathways (<xref ref-type="bibr" rid="bib18">Hanahan and Weinberg, 2011</xref>; <xref ref-type="bibr" rid="bib31">Lowe et al., 2004</xref>; <xref ref-type="bibr" rid="bib53">Shortt and Johnstone, 2012</xref>). This is likely because cells have evolutionarily refined fail-safe mechanisms to prevent tumorigenesis by a single oncogene activation. Because of this fail-safe mechanism, the transforming effects of oncogenes are often cancelled by the cell’s intrinsic ability to prevent tumorigenesis (<xref ref-type="bibr" rid="bib31">Lowe et al., 2004</xref>; <xref ref-type="bibr" rid="bib53">Shortt and Johnstone, 2012</xref>). Thus, transformation by oncogenic drivers requires inhibition of tumor suppressor signaling, which regulates cell death or senescence.</p><p>A well-known example of the fail-safe mechanism is the case of <italic>Myc</italic> oncogene. <italic>Myc</italic> is a potent oncogene implicated in most human tumor entities, but it is also a powerful cell death driver (<xref ref-type="bibr" rid="bib9">Evan et al., 1992</xref>; <xref ref-type="bibr" rid="bib20">Hoffman and Liebermann, 1998</xref>; <xref ref-type="bibr" rid="bib43">Prendergast, 1999</xref>). Originally, two models were proposed to explain the Myc-induced cell death (<xref ref-type="bibr" rid="bib10">Evan et al., 1994</xref>). The ‘conflict’ model suggests that, in an environment where proliferation is not supported, inappropriate growth signals induced by Myc invoke the cell’s intrinsic mechanisms to cease abnormal proliferation, leading to apoptosis. In this model, the main function of Myc is to induce proliferation, and cells undergo apoptosis in response to the aberrant growth signal. In contrast, the ‘dual’ model proposes that apoptosis occurs as a direct result of bona fide signaling of the Myc pathway, rather than as the cell’s response to Myc-invoked aberrant growth signaling. In this model, cell death is a normal, obligate function of Myc, which is intrinsically imprinted in the Myc signaling itself. Although these two models are not mutually exclusive, delineation of Myc signaling supports the dual model: Myc drives p53-mediated apoptosis through transcriptional regulation of the tumor suppressor ARF (<xref ref-type="bibr" rid="bib31">Lowe et al., 2004</xref>; <xref ref-type="bibr" rid="bib53">Shortt and Johnstone, 2012</xref>).</p><p>In addition to Myc, many other oncogenes are known to induce cell death. This phenomenon is now accepted as an intrinsic tumor suppressive mechanism (<xref ref-type="bibr" rid="bib53">Shortt and Johnstone, 2012</xref>). However, contrary to the well-studied mechanisms of Myc-induced cell death, how other oncogenes, such as <italic>Ras</italic> or <italic>Src</italic>, couple cell proliferation and death remains unclear (<xref ref-type="bibr" rid="bib31">Lowe et al., 2004</xref>).</p><p>In this study, we focus on the <italic>Src</italic> oncogene. <italic>Src</italic> is the first oncogene identified (<xref ref-type="bibr" rid="bib68">Yeatman, 2004</xref>). Src expression and activity is often increased in human cancer, which contributes to oncogenesis (<xref ref-type="bibr" rid="bib21">Ishizawar and Parsons, 2004</xref>; <xref ref-type="bibr" rid="bib60">Summy and Gallick, 2003</xref>; <xref ref-type="bibr" rid="bib68">Yeatman, 2004</xref>). Due to the implication of Src in tumorigenesis, many clinical inhibitors targeting Src family kinases (SFKs) have been developed but their use as therapeutic drugs has been unsuccessful (<xref ref-type="bibr" rid="bib13">Gargalionis et al., 2014</xref>; <xref ref-type="bibr" rid="bib58">Sousa-Victor and Jasper, 2014</xref>). The reason for the low efficacy of these Src inhibitors remains unclear because both SFKs and SFK inhibitors have a broad spectrum of targets, making mechanistic analyses difficult. This compels us to better understand how Src regulates signaling pathways.</p><p><italic>Drosophila</italic> has two SFKs: <italic>Src42A</italic> and <italic>Src64B</italic> (<xref ref-type="bibr" rid="bib28">Kussick et al., 1993</xref>; <xref ref-type="bibr" rid="bib41">Pedraza et al., 2004</xref>; <xref ref-type="bibr" rid="bib62">Takahashi et al., 1996</xref>). The endogenous expression patterns of <italic>Src42A</italic> and <italic>Src64</italic>B are different, but ectopic expression of either of them induces similar effects. <italic>Drosophila</italic> Src regulates a variety of signaling pathways, including Notch, MAPKs, Jak-Stat, EGF, Wnt, and Hippo signaling (<xref ref-type="bibr" rid="bib5">Cordero et al., 2014</xref>; <xref ref-type="bibr" rid="bib8">Enomoto and Igaki, 2013</xref>; <xref ref-type="bibr" rid="bib19">Ho et al., 2015</xref>; <xref ref-type="bibr" rid="bib44">Read et al., 2004</xref>; <xref ref-type="bibr" rid="bib64">Tateno et al., 2000</xref>). Src activation induces apoptosis as well as tissue growth (<xref ref-type="bibr" rid="bib41">Pedraza et al., 2004</xref>). However, how cell death and proliferation are coordinated downstream of Src activation still remains elusive. Here, we investigate how the <italic>Src</italic> oncogene couples cell proliferation and death in epithelia of the wing imaginal disc.</p></sec><sec id="s2" sec-type="results"><title>Results</title><p>Previous studies have shown that a <italic>Drosophila</italic> Src, Src42A, simultaneously induces cell death and proliferation in both eye and wing imaginal discs (<xref ref-type="bibr" rid="bib41">Pedraza et al., 2004</xref>). In this study, we used a <italic>vg-Gal4</italic> driver, which promotes local expression in the DV boundary and a part of the hinge region of the wing disc. Indeed, expression of constitutively active (CA) <italic>Src42A</italic> with an amino acid substitution of Tyr<sup>511</sup> to Phe, which is refractory to inactivating phosphorylation by Csk (<xref ref-type="bibr" rid="bib64">Tateno et al., 2000</xref>), induced both mitosis and apoptosis, which were detected by phospho-histone 3 (pH3) and cleaved caspase DCP1, respectively (<xref ref-type="fig" rid="fig1">Figure 1A–D</xref>). This provocation of both cell proliferation and death results in a mild overgrowth in the <italic>Src42A CA</italic>-expressing region, likely reflecting the mutually cancelling effects of proliferation and death. (<xref ref-type="fig" rid="fig1">Figure 1E</xref>).</p><fig id="fig1" position="float"><label>Figure 1.</label><caption><title>Src activation induces both cell proliferation and death, resulting in a mild tissue overgrowth.</title><p>(<bold>A</bold>) <italic>Src42A constitutively active</italic> (<italic>CA</italic>) expression induces cell proliferation, which was detected by phospho-histone 3 (pH3) staining. (<bold>B</bold>) Quantification of pH3 staining. The number of pH3+ cells was normalized by the area of GFP+ cells. Two-tailed unpaired t-test. (<bold>C</bold>) <italic>Src42A CA</italic> expression induces caspase activation, which was detected by cleaved DCP1 staining. (<bold>D</bold>) Quantification of percentage of cDCP1+ cells in GFP+ cells. Two-tailed unpaired t-test. (<bold>E</bold>) Quantification of the total volume of GFP+ cells (µm³). Two-tailed unpaired t-test. Scale bars, 100 µm.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-59809-fig1-v1.tif"/></fig><p>Src signaling mediates a myriad of pathways, but how these signals converge to produce specific phenotypes remains unclear, especially in the context of cell proliferation and death coupling. It has previously been shown that Src-induced cell death cannot be inhibited by <italic>p21</italic> overexpression, which suppresses cell proliferation (<xref ref-type="bibr" rid="bib41">Pedraza et al., 2004</xref>). But, since p21 directly inhibits the cell cycle through inhibition of Cyclin-dependent kinases, the most downstream component of proliferation signals, it still remains unclear whether Src-induced aberrant proliferation signals play a role in cell death.</p><p>In order to find how Src signaling drives both cell proliferation and death simultaneously and whether cell death occurs in response to proliferation signals, we reasoned that interrogation of downstream signaling provoked by Src activation will give us clues on how these two opposing phenotypes are driven by Src. To search for an effector downstream of Src, we performed an RNAi screening mainly focusing on cell death-related factors (<xref ref-type="supplementary-material" rid="supp1">Supplementary file 1</xref>). The screening took advantage of the organismal lethality induced by <italic>Src42A CA</italic> expression in the wing disc (<xref ref-type="fig" rid="fig2">Figure 2A</xref>). We searched for RNAis that could suppress this Src-induced lethality.</p><fig-group><fig id="fig2" position="float"><label>Figure 2.</label><caption><title>Inhibition of Slpr suppresses the phenotypes induced by Src activation.</title><p>(<bold>A</bold>) <italic>Src42A constitutively active</italic> (<italic>CA</italic>) expression in the wing disc induces organismal lethality, which is suppressed by knockdown of <italic>slpr</italic>. One-way ANOVA with Sidak’s post-test. (<bold>B</bold>) The small, disheveled wing phenotype of the rare escapers with Src42A CA is suppressed by knockdown of <italic>slpr</italic>. (<bold>C</bold>) Src42A CA-mediated JNK activation, which was detected by the TRE-RFP reporter, is suppressed by knockdown of <italic>slpr</italic>. (<bold>D</bold>) Quantification of TRE-RFP in C. One-way ANOVA with Sidak’s post-test. Scale bars, 100 µm.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-59809-fig2-v1.tif"/></fig><fig id="fig2s1" position="float" specific-use="child-fig"><label>Figure 2—figure supplement 1.</label><caption><title>Inhibition of Slpr suppresses the phenotypes induced by Src activation.</title><p>(<bold>A</bold>) In the first screening, 107 RNAi stocks were used. The numbers of survivors were counted. The blue color indicates that survivors have disheveled wings while the magenta color indicates that survivors have the recovered wing phenotype. (<bold>B</bold>) In the second screening, the RNAi stocks that produced more than two survivors in the first screening were used. The blue color indicates that survivors have disheveled wings while the magenta color indicates that survivors have the recovered wing phenotype. (<bold>C</bold>) RT-qPCR of <italic>slpr</italic> using RNA from the larval whole body. <italic>slpr</italic> RNAi BL32948 lowered the transcriptional expression of <italic>slpr</italic>. (<bold>D</bold>) <italic>Src42A</italic> expression in the eye imaginal disc with <italic>gmr-Gal4</italic> eliminates the adult eye, which can be suppressed by knockdown of <italic>slpr</italic>. Note that the disheveled wing phenotype induced by leaky expression of <italic>gmr-Gal4</italic> in the wing disc is also suppressed by knockdown of <italic>slpr</italic>. (<bold>E</bold>) <italic>Src42A</italic> expression in the eye disc induces organismal lethality during development, which is suppressed by <italic>slpr</italic> knockdown. Two-tailed unpaired t-test.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-59809-fig2-figsupp1-v1.tif"/></fig></fig-group><p>We identified that <italic>slipper</italic> (<italic>slpr</italic>), a mixed lineage kinase, regulates Src signaling. Src-induced lethality was suppressed by <italic>slpr</italic> knockdown (<xref ref-type="fig" rid="fig2">Figure 2A</xref> and <xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1A–B</xref>). We confirmed knockdown efficiency of the <italic>slpr</italic> RNAi (<xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1C</xref>) by RT-qPCR. Rare escapers of <italic>vg&gt;Src42A CA</italic> flies have small, disheveled wings, but <italic>slpr</italic> knockdown completely reversed this phenotype (<xref ref-type="fig" rid="fig2">Figure 2B</xref>, <xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1A</xref>). This is not an event that is observed only in the wing disc because Slpr inhibition in the eye disc also suppressed organismal lethality and the abnormal eye phenotype of escapers that are induced by the <italic>Src</italic> expression in the eye disc (<xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1D–E</xref>).</p><p>The link between Src and Slpr has not been previously known. Slpr was originally identified as a JNKKK, a MAPKKK that regulates JNK signaling (<xref ref-type="bibr" rid="bib59">Stronach and Perrimon, 2002</xref>). Src has long been known to regulate JNK signaling (<xref ref-type="bibr" rid="bib64">Tateno et al., 2000</xref>). Some effectors such as ubiquitin E2 complex Bendless (<xref ref-type="bibr" rid="bib32">Ma et al., 2013</xref>) and F-actin cytoskeleton (<xref ref-type="bibr" rid="bib8">Enomoto and Igaki, 2013</xref>; <xref ref-type="bibr" rid="bib11">Fernández et al., 2014</xref>; <xref ref-type="bibr" rid="bib46">Rudrapatna et al., 2014</xref>) have been shown to link Src and JNK. But how Src exactly regulates JNK signaling still remains elusive. We speculated that Slpr may link Src and JNK signaling. Indeed, <italic>slpr</italic> RNAi significantly suppressed Src-mediated activation of JNK, which was detected by the JNK activity reporter TRE-RFP (<xref ref-type="fig" rid="fig2">Figure 2C–D</xref>). This observation suggests that Slpr is a JNKKK that transduces Src activation to JNK signaling.</p><p>Although our findings that Slpr mediates Src-induced JNK activation are consistent with the previous literature showing that Slpr is a MAPKKK upstream of JNK, the effects of <italic>slpr</italic> knockdown on the wings and organismal survival over Src stress were perplexing. This is because a combination of JNK inhibition and Src activation is known to induce a massive overgrowth phenotype (<xref ref-type="bibr" rid="bib8">Enomoto and Igaki, 2013</xref>; <xref ref-type="bibr" rid="bib19">Ho et al., 2015</xref>). Indeed, simultaneously activating Src and suppressing JNK resulted in substantial overgrowth of the wing disc (<xref ref-type="fig" rid="fig3">Figure 3A–D</xref>) and complete organismal lethality (<xref ref-type="fig" rid="fig3">Figure 3E</xref>). On the other hand, combining Src activation and Slpr inhibition did not induce tissue overgrowth (<xref ref-type="fig" rid="fig3">Figure 3A–D</xref>). We found that Slpr inhibition suppressed both cell proliferation and apoptosis induced by Src whereas JNK inhibition suppressed only apoptosis but not cell proliferation (<xref ref-type="fig" rid="fig3">Figure 3A–D</xref>). We confirmed the same results with a different RNAi for <italic>slpr</italic> (<xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1A–D</xref>). This suggests that JNK inhibition-mediated suppression of apoptosis is responsible for the tumor overgrowth. Consistent with this idea, a combination of Src activation and apoptosis inhibition by microRNAs for reaper, hid and grim (<xref ref-type="bibr" rid="bib54">Siegrist et al., 2010</xref>), which inhibits DIAP1, also induced overgrowth, similar to JNK inhibition (<xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1E</xref>). On the other hand, a combination of Src activation and cell death induction enhanced survival over the Src tumor (<xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1F</xref>). Furthermore, the overgrowth phenotype induced by Src activation and JNK inhibition was suppressed by <italic>slpr</italic> knockdown (<xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1G–I</xref>). Taken together, these findings strongly imply that Slpr, which was originally identified as a MAPKKK upstream of JNK, regulates other signaling pathways along with the JNK pathway.</p><fig-group><fig id="fig3" position="float"><label>Figure 3.</label><caption><title>Slpr regulates both cell proliferation and cell death that are induced by Src activation.</title><p>(<bold>A</bold>) Apoptosis induced by Src42A constitutively active (CA) is suppressed by <italic>slpr</italic> RNAi and JNK DN. Note the aggressive overgrowth phenotype induced by combining Src with JNK DN. (<bold>B</bold>) JNK DN does not inhibit Src42A CA-mediated proliferation whereas slpr inhibition does. (<bold>C</bold>) Quantification of the total volume of GFP+ cells (µm³) in B. One-way ANOVA with Sidak’s post-test. (<bold>D</bold>) Quantification of phospho-histone 3 (pH3) staining in B. The number of pH3+ cells was normalized by the area of GFP+ cells. Src42A CA-induced proliferation is suppressed by knockdown of <italic>slpr</italic> but not by overexpression of <italic>JNK DN</italic>. One-way ANOVA with Sidak’s post-test. (<bold>E</bold>) Inhibition of JNK enhances organismal lethality induced by Src42A CA. One-way ANOVA with Sidak’s post-test. Scale bars, 100 µm.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-59809-fig3-v1.tif"/></fig><fig id="fig3s1" position="float" specific-use="child-fig"><label>Figure 3—figure supplement 1.</label><caption><title>Inhibition of Slpr suppresses the phenotypes induced by Src activation.</title><p>(<bold>A</bold>) <italic>slpr</italic> RNAi 33516GD suppresses Src-induced cell proliferation, similarly to <italic>slpr</italic> RNAi BL32948. (<bold>B</bold>) Quantification of phospho-histone 3 (pH3) staining in A. The number of pH3+ cells was normalized by the area of GFP+ cells. Src42A constitutively active (CA)-induced proliferation is suppressed by <italic>slpr</italic> knockdown with the 33516GD line. Two-tailed unpaired t-test. (<bold>C</bold>) <italic>slpr</italic> RNAi 33516GD suppresses Src-induced cell death, similarly to <italic>slpr</italic> RNAi BL32948. (<bold>D</bold>) RT-qPCR of <italic>slpr</italic> using RNA from the larval whole body. <italic>slpr</italic> RNAi 33516GD lowered the transcriptional expression of <italic>slpr</italic>. (<bold>E</bold>) Apoptosis induced by Src42A CA is suppressed by <italic>miRNA for rpr, hid, grim.</italic> (<bold>F</bold>) Induction of cell death by <italic>rpr-mts</italic> or <italic>egr</italic> suppressed organismal lethality induced by Src42A CA. One-way ANOVA with Sidak’s post-test. (<bold>G</bold>) Overgrowth induced by Src activation and JNK inhibition is suppressed by <italic>slpr</italic> knockdown. (<bold>H</bold>) Quantification of the total volume of GFP+ cells (µm³) in G. Two-tailed unpaired t-test. (<bold>I</bold>) Quantification of pH3 staining in G. The number of pH3+ cells was normalized by the area of GFP+ cells. Cell proliferation induced by Src activation and JNK inhibition is suppressed by <italic>slpr</italic> knockdown. Two-tailed unpaired t-test. Scale bars, 100 µm.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-59809-fig3-figsupp1-v1.tif"/></fig></fig-group><p>We investigated what is regulating proliferation downstream of the Src-Slpr axis if JNK only regulates cell death. Although Slpr was originally identified as a JNK regulator (<xref ref-type="bibr" rid="bib59">Stronach and Perrimon, 2002</xref>), subsequent studies report the existence of situations where Slpr can also activate other MAPKs including Erk and p38 (<xref ref-type="bibr" rid="bib3">Chen et al., 2010</xref>; <xref ref-type="bibr" rid="bib52">Sathyanarayana et al., 2003</xref>). Thus, we examined whether p38 and Erk could function as downstream components of Src-Slpr signaling. We found that Src activates both Erk and p38 in the wing disc (<xref ref-type="fig" rid="fig4">Figure 4A–B</xref> and <xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1A–C</xref>). Activated Erk and p38 were observed not only in the region that expresses <italic>Src</italic>, but also in the surrounding area together with non-cell autonomous proliferation (<xref ref-type="fig" rid="fig4">Figure 4A–B</xref>, <xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1A–D</xref>). In fact, there was also non-cell autonomous activation of JNK and cell death, albeit much subtler than Erk and p38 (<xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1E–G</xref>). This cell autonomous and non-cell autonomous activation of MAPKs by Src is similar to the activation patterns of Yorkie by Src (<xref ref-type="bibr" rid="bib8">Enomoto and Igaki, 2013</xref>). Inhibition of Slpr reduced Src-induced activation of both p38 and Erk (<xref ref-type="fig" rid="fig4">Figure 4A–B</xref> and <xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1A–B</xref>) cell autonomously, indicating that Slpr activates p38 and Erk in addition to JNK. It is of note that Slpr inhibition suppressed Src-induced non-cell autonomous activation of p38 but not Erk or JNK (<xref ref-type="fig" rid="fig4">Figure 4B</xref>, <xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1A–C,E</xref>), suggesting that there are different mechanisms that regulate non-cell autonomous activation of these MAPKs. In line with persistence of the non-cell autonomous JNK activation with Slpr inhibition, Slpr inhibition did not affect non-cell autonomous activation of caspase ( <xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1E, F, G</xref>). This suggests that Src-invoked proliferation does not occur as a compensatory proliferation induced by death of the surrounding cells.</p><fig-group><fig id="fig4" position="float"><label>Figure 4.</label><caption><title>p38 mediates Src-induced cell proliferation.</title><p>(<bold>A</bold>) <italic>Src42A constitutively active </italic>(<italic>CA</italic>) expression induces phosphorylation of p38 both cell autonomously and non-cell autonomously, which is suppressed by <italic>slpr</italic> knockdown. (<bold>B</bold>) Quantification of phosphorylated p38 in A. One-way ANOVA with Sidak’s post-test. (<bold>C</bold>) Src42A CA-induced proliferation with/without JNK inhibition is suppressed by p38 DN. (<bold>D</bold>) Quantification of the total volume of GFP+ cells (µm³) in <bold>C</bold>. Two-tailed unpaired t-test. (<bold>E</bold>) Quantification of phospho-histone 3 (pH3) staining in <bold>C</bold>. The number of pH3+ cells was normalized by the area of GFP+ cells. Two-tailed unpaired t-test. (<bold>F</bold>) Inhibition of p38 suppresses organismal lethality induced by Src42A CA. One-way ANOVA with Sidak’s post-test. Scale bars, 100 µm.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-59809-fig4-v1.tif"/></fig><fig id="fig4s1" position="float" specific-use="child-fig"><label>Figure 4—figure supplement 1.</label><caption><title>Erk is activated downstream of Src-Slpr signaling but does not mediate cell proliferation.</title><p>(<bold>A</bold>) <italic>Src42A constitutively active</italic> (<italic>CA</italic>) expression induces phosphorylation of Erk both cell autonomously and non-cell autonomously, which is suppressed by <italic>slpr</italic> knockdown. (<bold>B</bold>) Quantification of phosphorylated Erk in A. One-way ANOVA with Sidak’s post-test. (<bold>C</bold>) A high magnification picture demonstrating that <italic>Src42A CA</italic> expression induces phosphorylation of p38 both cell autonomously and non-cell autonomously, which is suppressed by <italic>slpr</italic> knockdown. (<bold>D</bold>) Src42 CA-induced non-cell autonomous proliferation is suppressed by <italic>slpr</italic> knockdown. One-way ANOVA with Sidak’s post-test. (<bold>E</bold>) Quantification of TRE-RFP in GFP-negative cells in <xref ref-type="fig" rid="fig2">Figure 2C</xref>. <italic>Src42A CA</italic> expression induces non-cell autonomous JNK activation, which is not suppressed by <italic>slpr</italic> knockdown. One-way ANOVA with Sidak’s post-test. (<bold>F</bold>) <italic>Src42A CA</italic> expression induces apoptosis both cell autonomously and non-cell autonomously. <italic>slpr</italic> knockdown suppresses Src42A CA-induced cell autonomous apoptosis but not non-cell autonomous one. (<bold>G</bold>) Quantification of percentage of cDCP1+ cells in GFP- cells in F. One-way ANOVA with Sidak’s post-test. (<bold>H</bold>) Knockdown of <italic>erk</italic> worsens organismal survival over the Src stress. Two-tailed unpaired t-test. (<bold>I</bold>) Inhibition of Erk does not inhibit cell proliferation induced by Src42A CA and JNK DN. (<bold>J</bold>) The <italic>erk</italic> RNAi stock suppresses the <italic>RasV12-</italic>induced rough eye phenotype, validating its knockdown. Scale bars, 100 µm.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-59809-fig4-figsupp1-v1.tif"/></fig><fig id="fig4s2" position="float" specific-use="child-fig"><label>Figure 4—figure supplement 2.</label><caption><title>p38 inhibition does not inhibit Src-induced apoptosis.</title><p>(<bold>A</bold>) Src42A constitutively active (CA)-induced proliferation is suppressed by p38 inhibition. (<bold>B</bold>) Quantification of the total volume of GFP+ cells in A. p38 inhibition suppresses Src42A CA-induced proliferation. Two-tailed unpaired t-test. (<bold>C</bold>) Quantification of phospho-histone 3 (pH3) staining in A. The number of pH3+ cells was normalized by the area of GFP+ cells. Two-tailed unpaired t-test. (<bold>D</bold>) Cell proliferation induced by Src42A CA and JNK inhibition is suppressed by <italic>lic</italic> knockdown. (<bold>E</bold>) Quantification of the total volume of GFP+ cells in D. Two-tailed unpaired t-test. (<bold>F</bold>) Quantification of pH3 staining in D. The number of pH3+ cells was normalized by the area of GFP+ cells. Cell proliferation induced by Src42A CA and JNK inhibition is suppressed by <italic>lic</italic> knockdown. Two-tailed unpaired t-test. (<bold>G</bold>) Inhibition of p38 does not suppress DCP1 activation induced by Src42A CA. (<bold>H</bold>) Quantification of the volume of apoptotic cells in the <italic>Src42A</italic> CA expressing region. p38 inhibition does not affect the volume of cDCP1+ cells. Two-tailed unpaired t-test. (<bold>I</bold>) Percentage of cDCP1+ cells in GFP+ cells. Since p38 inhibition decreases proliferation but not the volume of cDCP1+ cells, the percentage of cDCP1+ cells in GFP+ cells increases by p38 inhibition. Two-tailed unpaired t-test. Scale bars, 100 µm.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-59809-fig4-figsupp2-v1.tif"/></fig></fig-group><p>Next, we investigated which of p38 or Erk might be involved in Src-induced cell proliferation. When we inhibited Erk using several RNAis that had previously been utilized (<xref ref-type="bibr" rid="bib55">Singh et al., 2016</xref>), Erk inhibition was unable to reverse Src-induced organismal lethality and proliferation (<xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1H–I</xref>). We also verified that the <italic>erk</italic> RNAi we used could inhibit the rough eye phenotype induced by Ras activation (<xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1J</xref>). This indicates that, even though Src-Slpr signaling activates Erk, its functional contribution to proliferation is negligible. In fact, Erk inhibition lowered survival over <italic>Src</italic> expression, implying that Src-Slpr-Erk signaling is protective for animals through an unknown mechanism. On the other hand, when we inhibited p38 in the <italic>Src-</italic>expressing region, it suppressed cell proliferation (<xref ref-type="fig" rid="fig4">Figure 4C–E</xref>), regardless of the existence of JNK inhibition (<xref ref-type="fig" rid="fig4s2">Figure 4—figure supplement 2A–C</xref>). Furthermore, inhibition of the p38 MAPKK, Licorne (Lic) (<xref ref-type="bibr" rid="bib6">Cully et al., 2010</xref>), suppressed Src-induced proliferation (<xref ref-type="fig" rid="fig4s2">Figure 4—figure supplement 2D–F</xref>). p38 inhibition also suppressed Src-induced lethality (<xref ref-type="fig" rid="fig4">Figure 4F</xref>). Importantly, p38 suppression did not inhibit Src-mediated apoptosis (<xref ref-type="fig" rid="fig4s2">Figure 4—figure supplement 2G–I</xref>). We conclude that, downstream of Src-Slpr, p38 regulates cell proliferation without affecting apoptosis.</p><p>Since Src activates both proliferation and cell death through two MAPK signaling pathways emanating from Slpr, we reasoned that inhibition of p38-mediated proliferation will be beneficial for a potential therapeutic purpose, uncoupling the link between cell death and proliferation. However, since p38 itself could still activate multiple signaling pathways, we decided to further delineate how p38 regulates cell proliferation, aiming to find a way to uncouple proliferation and cell death in a specific manner.</p><p>First we focused on Mef2 and Atf2, the transcription factors that are known to be regulated by p38 (<xref ref-type="bibr" rid="bib1">Adachi-Yamada et al., 1999</xref>; <xref ref-type="bibr" rid="bib51">Sano et al., 2005</xref>; <xref ref-type="bibr" rid="bib66">Vrailas-Mortimer et al., 2011</xref>). Using the previously published RNAis for <italic>mef2</italic> or <italic>atf2</italic> (<xref ref-type="bibr" rid="bib4">Clark et al., 2013</xref>; <xref ref-type="bibr" rid="bib65">Terriente-Félix et al., 2017</xref>) did not suppress aggressive tumorigenesis induced by simultaneous Src activation and JNK inhibition (<xref ref-type="fig" rid="fig5s1">Figure 5—figure supplement 1A</xref>).</p><p>We next shifted our focus to Tor signaling since p38 also regulates cell proliferation through Tor (<xref ref-type="bibr" rid="bib6">Cully et al., 2010</xref>). Tor is a central growth regulator that transduces nutritional information to cell growth (<xref ref-type="bibr" rid="bib26">Kim and Guan, 2019</xref>; <xref ref-type="bibr" rid="bib48">Sabatini, 2017</xref>). We examined whether Src activates Tor signaling. Phosphorylation of 4EBP, a readout of Tor signaling activation, was enhanced by <italic>Src</italic> expression (<xref ref-type="fig" rid="fig5">Figure 5A–B</xref>). Src also promoted phosphorylation of S6, another readout of Tor signaling (<xref ref-type="bibr" rid="bib25">Kim et al., 2017</xref>, <xref ref-type="fig" rid="fig5s1">Figure 5—figure supplement 1B–C</xref>). Src-induced phosphorylation of 4EBP and of S6 could be suppressed by Slpr or p38 inhibition, but not by JNK inhibition (<xref ref-type="fig" rid="fig5">Figure 5A–B</xref>, <xref ref-type="fig" rid="fig5s1">Figure 5—figure supplement 1B–C</xref>), indicating that Tor signaling functions downstream of the Src-Slpr-p38 axis. We then investigated whether Tor inhibition can suppress the massive overgrowth induced by Src activation and JNK inhibition. Tor inhibition completely suppressed overgrowth induced by Src activation and JNK inhibition (<xref ref-type="fig" rid="fig5">Figure 5C</xref>). Taken together, these findings indicate that p38 regulates cell proliferation through Tor signaling.</p><fig-group><fig id="fig5" position="float"><label>Figure 5.</label><caption><title>Tor signaling functions downstream of the Src-p38 pathway.</title><p>(<bold>A</bold>) Src42A constitutively active (CA) induces phosphorylation of 4EBP, a readout of Tor activation. Src42A CA-mediated phosphorylation of 4EBP was suppressed by p38 inhibition but not by JNK inhibition. (<bold>B</bold>) Quantification of phosphorylated 4EBP in A. One-way ANOVA with Sidak’s post-test. (<bold>C</bold>) Knockdown of <italic>Tor</italic> suppresses Src42A CA-induced cell proliferation. Scale bars, 100 µm.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-59809-fig5-v1.tif"/></fig><fig id="fig5s1" position="float" specific-use="child-fig"><label>Figure 5—figure supplement 1.</label><caption><title>Inhibition of Mef2 or Atf2 does not suppress Src42A constitutively active (CA)-induced cell proliferation.</title><p>(<bold>A</bold>) Knockdown of <italic>mef2</italic> or <italic>atf2</italic>, well-known downstream factors of p38, does not suppress Src42A CA-induced proliferation. (<bold>B</bold>) Src42A CA induces phosphorylation of S6, another readout of Tor activation. Src42A CA-mediated phosphorylation of S6 was suppressed by p38 inhibition or <italic>slpr</italic> knockdown but not by JNK inhibition. (<bold>C</bold>) Quantification of phosphorylated S6 in B. One-way ANOVA with Sidak’s post-test. Scale bars, 100 µm.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-59809-fig5-figsupp1-v1.tif"/></fig></fig-group><p>Tor functions as a nutrient sensor, which can be regulated by manipulation of diet organisms eat. Since dietary manipulation of nutrients, including sugar and amino acids, affects clinical cancer outcome (<xref ref-type="bibr" rid="bib2">Badgley et al., 2020</xref>; <xref ref-type="bibr" rid="bib7">DeBerardinis and Chandel, 2016</xref>; <xref ref-type="bibr" rid="bib12">Gao et al., 2019</xref>; <xref ref-type="bibr" rid="bib15">Goncalves et al., 2019</xref>; <xref ref-type="bibr" rid="bib16">Gonzalez et al., 2018</xref>; <xref ref-type="bibr" rid="bib22">Kanarek et al., 2018</xref>; <xref ref-type="bibr" rid="bib27">Knott et al., 2018</xref>; <xref ref-type="bibr" rid="bib33">Maddocks et al., 2013</xref>; <xref ref-type="bibr" rid="bib34">Maddocks et al., 2017</xref>; <xref ref-type="bibr" rid="bib40">Pavlova and Thompson, 2016</xref>), we investigated whether dietary manipulation of nutrition can mimic the phenotype of Tor or p38 inhibition. We found that simple dilution of yeast in the fly food suppressed the tumor overgrowth and Tor activation that are induced by Src activation and JNK inhibition (<xref ref-type="fig" rid="fig6">Figure 6A–D</xref>). Yeast dilution did not affect Src-induced p38 activation (<xref ref-type="fig" rid="fig6s1">Figure 6—figure supplement 1A–B</xref>), suggesting that nutrition signaling does not function upstream of p38. Importantly, yeast dilution increased survival over the Src-induced stress (<xref ref-type="fig" rid="fig6">Figure 6E</xref>), demonstrating the connection between organismal physiology and tumorigenesis.</p><fig-group><fig id="fig6" position="float"><label>Figure 6.</label><caption><title>Yeast dilution affects Src-induced Tor signaling, tissue growth, and organismal lethality.</title><p>(<bold>A-B</bold>) Dietary restriction of yeast suppresses both Src42A constitutively active (CA)-induced proliferation and phosphorylation of 4EBP. (<bold>C</bold>) Quantification of the total volume of GFP+ cells (µm³) in A-B. Mann-Whitney test. (<bold>D</bold>) Quantification of phosphorylated 4EBP in A-B. Two-tailed unpaired t-test. (<bold>E</bold>) Dietary restriction of yeast reduces organismal lethality caused by <italic>Src42A CA</italic> expression in the wing disc in a dose-dependent manner. One-way ANOVA with Sidak’s post-test.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-59809-fig6-v1.tif"/></fig><fig id="fig6s1" position="float" specific-use="child-fig"><label>Figure 6—figure supplement 1.</label><caption><title>Yeast dilution does not affect Src-induced p38 phosphorylation.</title><p>(<bold>A</bold>) Yeast dilution does not suppress phosphorylation of p38 induced by Src42A constitutively active (CA). (<bold>B</bold>) Quantification of phosphorylated p38 in A. Both cell autonomous and non-cell autonomous p38 activation by Src42A CA are not suppressed by dietary restriction of yeast. Two-tailed unpaired t-test. Scale bars, 50 µm.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-59809-fig6-figsupp1-v1.tif"/></fig></fig-group><p>Since yeast contains large amounts of amino acids, which activate Tor signaling (<xref ref-type="bibr" rid="bib26">Kim and Guan, 2019</xref>; <xref ref-type="bibr" rid="bib48">Sabatini, 2017</xref>), we investigated which amino acid might be involved in transformation by Src. To narrow down candidate amino acids, we compared the effects of essential amino acids and non-essential amino acids on survival over Src-induced stress. Feeding of essential amino acids, but not non-essential ones, enhanced lethality induced by <italic>Src</italic> expression (<xref ref-type="fig" rid="fig7">Figure 7A</xref>). We further narrowed down the responsible amino acid by repeating the essential amino acid feeding experiment, but this time subtracting each essential amino acid from the mixture one by one (<xref ref-type="fig" rid="fig7">Figure 7B</xref>). Out of all the essential amino acids, only methionine subtraction reversed lethality of the Src-activated flies induced by feeding essential amino acids (<xref ref-type="fig" rid="fig7">Figure 7B</xref>). This methionine specificity was unexpected because a variety of dietary amino acids, including serine, glycine, histidine, asparagine, cysteine, and methionine, have been shown to affect cancer outcome in mammals (<xref ref-type="bibr" rid="bib2">Badgley et al., 2020</xref>; <xref ref-type="bibr" rid="bib12">Gao et al., 2019</xref>; <xref ref-type="bibr" rid="bib22">Kanarek et al., 2018</xref>; <xref ref-type="bibr" rid="bib27">Knott et al., 2018</xref>; <xref ref-type="bibr" rid="bib33">Maddocks et al., 2013</xref>; <xref ref-type="bibr" rid="bib34">Maddocks et al., 2017</xref>). We found that methionine addition reduces the survival over the Src-induced stress (<xref ref-type="fig" rid="fig7">Figure 7C</xref>), whereas it does not affect survival of control animals (<xref ref-type="fig" rid="fig7s1">Figure 7—figure supplement 1A</xref>). Even in a detrimental situation where apoptosis is inhibited by JNK DN, methionine manipulation could affect the organismal survival over the Src-induced stress (<xref ref-type="fig" rid="fig7s1">Figure 7—figure supplement 1B</xref>).</p><fig-group><fig id="fig7" position="float"><label>Figure 7.</label><caption><title>Methionine regulates Src-induced Tor signaling, tissue growth, and organismal lethality.</title><p>(<bold>A</bold>) Addition of essential amino acids enhances organismal lethality caused by <italic>Src42A constitutively active</italic> (<italic>CA</italic>) expression in the wing disc, whereas addition of non-essential amino acids does not. Kruskal-Wallis test with Dunn’s post-test. (<bold>B</bold>) Only methionine subtraction from the diet improves organismal survival over the Src42A CA stress. One-way ANOVA with Sidak’s post-test. (<bold>C</bold>) Addition of methionine reduces organismal survival over the Src42A CA stress in a dose-dependent manner. One-way ANOVA with Sidak’s post-test. (<bold>D</bold>) An amount of methionine in the hemolymph was measured by LC-MS/MS. Expression of <italic>Src42A CA</italic> in the wing disc decreases the circulating methionine in the hemolymph. Two-tailed unpaired t-test. (<bold>E-F</bold>) Dietary methionine activates both cell proliferation and phosphorylation of 4EBP that are induced by Src42A CA and JNK DN. (<bold>G</bold>) Quantification of the total volume of GFP+ cells (µm³) in E-F. Mann-Whitney test. (<bold>H</bold>) Quantification of phosphorylated 4EBP in E-F. Two-tailed unpaired t-test. (<bold>I</bold>) <italic>SamS</italic> knockdown suppresses phosphorylation of 4EBP and overgrowth induced by Src42A CA and JNK DN. (<bold>J</bold>) Quantification of the total volume of GFP+ cells (µm³) in I. One-way ANOVA with Sidak’s post-test. (K) Quantification of phosphorylated 4EBP in I. One-way ANOVA with Sidak’s post-test. Scale bars, 100 µm.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-59809-fig7-v1.tif"/></fig><fig id="fig7s1" position="float" specific-use="child-fig"><label>Figure 7—figure supplement 1.</label><caption><title>Involvement of amino acids in Src-induced oncogenic stress.</title><p>(<bold>A</bold>) Methionine addition does not affect survival of control flies without tumor burden. One-way ANOVA with Sidak’s post-test. (<bold>B</bold>) The graph shows which stage animals could reach. Dietary restriction of yeast suppresses organismal lethality induced by <italic>Src42A constitutively active</italic> (<italic>CA</italic>) overexpression with JNK inhibition. Methionine supplementation suppresses the dietary restriction-mediated effect on organismal lethality. (<bold>C</bold>) The concentrations of EAAs in the hemolymph were measured by CE-MS. (<bold>D</bold>) The concentrations of NEAAs in the hemolymph were measured by CE-MS.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-59809-fig7-figsupp1-v1.tif"/></fig><fig id="fig7s2" position="float" specific-use="child-fig"><label>Figure 7—figure supplement 2.</label><caption><title>Involvement of methionine in Src-induced Tor activation.</title><p>(<bold>A</bold>) Neither dietary restriction of yeast nor methionine supplementation affects Src42A constitutively active (CA)-induced apoptosis. (<bold>B-C</bold>) Dietary restriction of yeast reduces the wing tissue development, which is estimated by the size of wings. Methionine supplementation does not rescue the tissue growth defects caused by yeast restriction. One-way ANOVA with Sidak’s post-test. (<bold>D</bold>) <italic>Samtor</italic> knockdown enhances Tor activation induced by Src42A CA and JNK DN in a diluted yeast condition, where Tor activation is suppressed. On the other hand, the overgrowth phenotype induced by Src42A CA and JNK DN was suppressed. (<bold>E</bold>) Quantification of the total volume of GFP+ cells (µm³) in D. Two-tailed unpaired t-test. (<bold>F</bold>) Quantification of phosphorylated S6 in D. Two-tailed unpaired t-test. Scale bars, 100 µm.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-59809-fig7-figsupp2-v1.tif"/></fig></fig-group><p>We also investigated whether Src-induced tumor can cause a systemic effect on the nutritional state at the organismal level. Since tumor burden is clinically known to affect the amino acid profiles in the blood (<xref ref-type="bibr" rid="bib29">Lai et al., 2005</xref>), we performed metabolomics analysis of the hemolymph, the fly blood, from the flies that bear Src-induced tumor in the wing discs. This metabolomics analysis revealed that the methionine concentration in the hemolymph is significantly decreased in flies that bear Src-induced tumors compared to control flies (<xref ref-type="fig" rid="fig7">Figure 7D</xref> and <xref ref-type="fig" rid="fig7s1">Figure 7—figure supplement 1C–D</xref>), which is correlated with the effects of dietary manipulation of methionine.</p><p>The correlative data on methionine in the amino acid subtraction experiment and the hemolymph analysis prompted us to investigate the role of methionine in Src-mediated oncogenesis. Feeding methionine enhanced Src-induced Tor signaling and overgrowth (<xref ref-type="fig" rid="fig7">Figure 7E–H</xref>), indicating that methionine is at least partly responsible for the nutrition-mediated activation of Tor signaling in Src-mediated tumors. Methionine addition did not affect Src-induced caspase activation (<xref ref-type="fig" rid="fig7s2">Figure 7—figure supplement 2A</xref>). Requirement of methionine for cell proliferation was relatively specific to tumor growth, because, under a normal condition without tumor, addition of methionine could not reverse the effects of yeast dilution, which induces smaller adult wings in control (<xref ref-type="fig" rid="fig7s2">Figure 7—figure supplement 2B–C</xref>).</p><p>Methionine can activate Tor through its conversion to SAM, a universal methyl donor (<xref ref-type="bibr" rid="bib17">Gu et al., 2017</xref>). Consistently, inhibition of Sam synthetase, which converts methionine to SAM (<xref ref-type="bibr" rid="bib38">Obata and Miura, 2015</xref>), suppressed both Src-induced overgrowth and Tor activation (<xref ref-type="fig" rid="fig7">Figure 7I–K</xref>). This indicates that methionine regulates Tor signaling in Src tumors in a tissue-autonomous manner. We also investigated a role for Samtor in Src-mediated oncogenesis. Samtor is a recently identified SAM sensor that inhibits Tor, which is released by SAM, in both mammals and <italic>Drosophila</italic> (<xref ref-type="bibr" rid="bib17">Gu et al., 2017</xref>). As expected, in a diluted yeast condition, which suppresses Tor activation, <italic>samtor</italic> knockdown enhanced Tor activation with Src (<xref ref-type="fig" rid="fig7s2">Figure 7—figure supplement 2D–F</xref>). Unexpectedly, however, <italic>samtor</italic> knockdown suppressed Src-mediated overgrowth in spite of its Tor activation. We speculate that this growth suppression is likely attributed to Samtor’s predicted methyltransferase function, which may not be related to Tor signaling. All together, these data indicate that methionine mediates Tor activation during Src-induced oncogenesis.</p><p>Finally, we explored a potential cross talk between Src-p38-Tor signaling and methionine-mediated Tor regulation. First, we investigated whether Src can activate methionine metabolism directly. Since <italic>Src</italic> expression in the wing disc lowers the methionine concentration in the hemolymph (<xref ref-type="fig" rid="fig7">Figure 7D</xref>), we hypothesized that Src tumors may uptake more methionine. Consistent with this idea, Src tumors uptake more methionine than control, which was demonstrated by performing an <italic>in vitro</italic> culture of the wing disc with a methionine analog homopropargylglycine (HPG) (<xref ref-type="fig" rid="fig8">Figure 8A–B</xref>). Furthermore, Src tumors exhibit a higher ratio of SAM to methionine (<xref ref-type="fig" rid="fig8">Figure 8C</xref>), indicating enhanced methionine flux to SAM. Collectively, Src enhances methionine uptake and methionine flux. Interestingly, this Src-mediated control of methionine metabolism was independent of p38 (<xref ref-type="fig" rid="fig8">Figure 8D–F</xref>, <xref ref-type="fig" rid="fig8s1">Figure 8—figure supplement 1A</xref>), suggesting that Src does activate methionine metabolism but not through p38.</p><fig-group><fig id="fig8" position="float"><label>Figure 8.</label><caption><title>Cross talk between Src signaling and methionine-Tor signaling.</title><p>(<bold>A</bold>) An <italic>in vitro</italic> culture of the wing disc with a methionine analog homopropargylglycine (HPG) demonstrates that the tumor disc induced by Src42A constitutively active (CA) and JNK DN uptakes more methionine than the control disc. (<bold>B</bold>) Quantification of the HPG intensity in A. Two-tailed unpaired t-test. (<bold>C</bold>) The amounts of methionine and SAM in the wing discs were measured by LC-MS. The tumor disc induced by Src42A CA and JNK DN contains a higher amount of SAM, whereas the amount of methionine is not significantly different. Methionine flux was calculated as a ratio of SAM and methionine. Two-tailed unpaired t-test. (<bold>D</bold>) The increase of methionine incorporation in the Src tumor is not mediated by p38. (<bold>E</bold>) Quantification of the HPG intensity in D. One-way ANOVA with Sidak’s post-test. (<bold>F</bold>) p38 inhibition does not suppress the upregulated methionine flux by Src42A CA and JNK DN. Two-tailed unpaired t-test. (<bold>G</bold>) A schematic of the Src42A CA-mediated coupling of cell proliferation and death. JNK activates cell death, while p38 activates cell proliferation, which is regulated by methionine-mediated Tor signaling. Scale bars, 100 µm.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-59809-fig8-v1.tif"/></fig><fig id="fig8s1" position="float" specific-use="child-fig"><label>Figure 8—figure supplement 1.</label><caption><title>Cross-talk between Src signaling and Tor signaling.</title><p>(<bold>A</bold>) The data show the amounts of methionine and SAM in wing discs, which were used to calculate methionine flux in <xref ref-type="fig" rid="fig8">Figure 8F</xref>. p38 inhibition does not affect the amounts of methionine and SAM in tumorous discs induced by Src42A constitutively active (CA) and JNK DN. Two-tailed unpaired t-test. (<bold>B</bold>) A schematic of Src42A CA-mediated Tor regulation. Src activates Tor pathway via both p38-dependent and -independent pathways. Src promotes methionine incorporation and methionine metabolism flux independently of p38, which could activate Tor. On the other hand, Src increases expression of an amino acid transporter, <italic>path</italic>, in a p38-dependent manner, which could also activate Tor activity through uptake of non-methionine amino acids. (<bold>C</bold>) <italic>RasV12</italic> expression in the wing imaginal disc induces small wings. Knockdown of <italic>slpr</italic> reverses the wing phenotype induced by RasV12.(<bold>D</bold>) <italic>RasV12</italic> expression in the wing discs induces organismal lethality during development. Knockdown of <italic>slpr</italic> suppresses organismal lethality induced by <italic>RasV12</italic> expression in the wing discs. Two-tailed unpaired t-test. (<bold>E</bold>) RT-qPCR of amino acid transporters using RNA from wing discs. One-way ANOVA with Sidak’s post-test. (<bold>F</bold>) RT-qPCR of GATOR1/2 components using RNA from wing discs. One-way ANOVA with Sidak’s post-test.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-59809-fig8-figsupp1-v1.tif"/></fig></fig-group></sec><sec id="s3" sec-type="discussion"><title>Discussion</title><p>Here, we elucidated the mechanism by which Src drives cell proliferation and cell death in an obligatory coupled manner. The obligation is mediated by coupling of two MAPK pathways diverging from the lynchpin protein Slpr. Downstream of Slpr, JNK activates cell death signaling, while p38 activates cell proliferation in a methionine-Tor dependent manner (<xref ref-type="fig" rid="fig8">Figure 8G</xref>). Src can potentially regulate Tor signaling through both p38-dependent and -independent mechanisms (<xref ref-type="fig" rid="fig8s1">Figure 8—figure supplement 1B</xref>). Our work provides several new insights discussed below.</p><p>First, our findings that Slpr mediates Src signaling provide a new molecular insight into regulation of Src signaling. <italic>Drosophila</italic> Src has been known to regulate various signaling pathways, including Notch, MAPKs, Jak-Stat, EGF, Wnt, and Hippo signaling (<xref ref-type="bibr" rid="bib5">Cordero et al., 2014</xref>; <xref ref-type="bibr" rid="bib8">Enomoto and Igaki, 2013</xref>; <xref ref-type="bibr" rid="bib19">Ho et al., 2015</xref>; <xref ref-type="bibr" rid="bib44">Read et al., 2004</xref>; <xref ref-type="bibr" rid="bib64">Tateno et al., 2000</xref>), but Slpr has not previously been implicated in Src signaling. Especially, the mechanism behind Src-mediated JNK activation was elusive in spite of its biological importance in various contexts. Slpr fills in the gap between Src and JNK. In hindsight, it may seem sensible that Slpr, a JNKKK, could link Src and JNK. However, previous studies proposed that ubiquitin E2 complex Bendless (<xref ref-type="bibr" rid="bib32">Ma et al., 2013</xref>) and F-actin cytoskeleton (<xref ref-type="bibr" rid="bib8">Enomoto and Igaki, 2013</xref>; <xref ref-type="bibr" rid="bib11">Fernández et al., 2014</xref>; <xref ref-type="bibr" rid="bib46">Rudrapatna et al., 2014</xref>) mediate Src-JNK signaling. Thus, it was unclear until now whether a MAPKKK is necessary for Src-mediated activation of JNK. Furthermore, there are five <italic>Drosophila</italic> JNKKKs, including dTAK1, Mekk1, Ask1, Wnd, and Slpr (<xref ref-type="bibr" rid="bib37">Nihalani et al., 2001</xref>; <xref ref-type="bibr" rid="bib47">Ryabinina et al., 2006</xref>; <xref ref-type="bibr" rid="bib59">Stronach and Perrimon, 2002</xref>; <xref ref-type="bibr" rid="bib63">Takatsu et al., 2000</xref>; <xref ref-type="bibr" rid="bib67">Wassarman et al., 1996</xref>), each of which functions uniquely in a context-dependent manner. In our initial RNAi screening that identified Slpr as a Src effector, other MAPKKKs were not identified (<xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1A</xref> and <xref ref-type="supplementary-material" rid="supp1">Supplementary file 1</xref>). Thus, identification of Slpr as a linker between Src and JNK provides a new insight. An urging, next question is how Src regulates Slpr. We speculate that the components that are considered as Src downstream and/or Slpr; upstream, such as Dok, Shark, and Misshapen (<xref ref-type="bibr" rid="bib45">Ríos-Barrera and Riesgo-Escovar, 2013</xref>), may mediate the signal transduction between them. Interestingly, we also found that Slpr inhibition suppresses the phenotype of CA <italic>Ras</italic> overexpression (<xref ref-type="fig" rid="fig8s1">Figure 8—figure supplement 1C, D</xref>), which, similar to Src, simultaneously induces apoptosis and proliferation (<xref ref-type="bibr" rid="bib23">Karim and Rubin, 1998</xref>). This suggests that Slpr could function as a lynchpin hub that integrates inputs from multiple oncogenes.</p><p>In this study, we exclusively focused on cell autonomous signaling induced by Src. But we noticed that Src elicits non-cell autonomous activation of MAPKs, cell death, and proliferation (<xref ref-type="fig" rid="fig4">Figure 4A–B</xref>, <xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1A–G</xref>), which is reminiscent of the non-cell autonomous activation of Yorkie by Src (<xref ref-type="bibr" rid="bib8">Enomoto and Igaki, 2013</xref>). It will be interesting to elucidate how non-cell autonomous signaling is regulated by Src activation in a future study.</p><p>Second, although Src was known to induce apoptosis as well as cell proliferation, how Src accomplishes this was unclear. We elucidated that, diverging from Slpr, p38 accelerates cell proliferation and that JNK induces cell death. This is an obligatory coupling of proliferation and death, likely being accomplished through evolution as an imperative mechanism to prevent tumorigenesis by a single oncogene activation. This type of fail-safe mechanism to prevent facile transformation was previously suggested in a context of <italic>Myc</italic> oncogene. We propose that, although each oncogene should have its unique fail-safe mechanism, the concept of the intrinsic fail-safe mechanism to prevent oncogenesis by a single oncogene is general.</p><p>Third, from a therapeutic perspective, our observation that methionine strongly regulates Src-mediated overgrowth is intriguing. Tumor growth <italic>in vitro</italic> is metabolically regulated by nutrition (<xref ref-type="bibr" rid="bib7">DeBerardinis and Chandel, 2016</xref>; <xref ref-type="bibr" rid="bib40">Pavlova and Thompson, 2016</xref>) and dietary manipulation of serine, glycine, histidine, asparagine, cysteine, or methionine could clinically modulate cancer outcome (<xref ref-type="bibr" rid="bib2">Badgley et al., 2020</xref>; <xref ref-type="bibr" rid="bib12">Gao et al., 2019</xref>; <xref ref-type="bibr" rid="bib22">Kanarek et al., 2018</xref>; <xref ref-type="bibr" rid="bib27">Knott et al., 2018</xref>; <xref ref-type="bibr" rid="bib33">Maddocks et al., 2013</xref>; <xref ref-type="bibr" rid="bib34">Maddocks et al., 2017</xref>). Notably, in our physiological <italic>in vivo</italic> condition, only subtraction of methionine from diet enhances organismal survival over Src-mediated oncogenic stress. Methionine has been studied in contexts of life span, metabolic health, and cancer together with other amino acids (<xref ref-type="bibr" rid="bib12">Gao et al., 2019</xref>; <xref ref-type="bibr" rid="bib30">Lee et al., 2014</xref>; <xref ref-type="bibr" rid="bib35">Malloy et al., 2013</xref>; <xref ref-type="bibr" rid="bib38">Obata and Miura, 2015</xref>; <xref ref-type="bibr" rid="bib39">Orentreich et al., 1993</xref>; <xref ref-type="bibr" rid="bib49">Sanderson et al., 2019</xref>), but the molecular mechanisms behind methionine-mediated cellular and organismal physiology were often unclear. We demonstrate that methionine regulates Tor activation, which controls cell proliferation induced by Src-p38 signaling.</p><p>In this study, we also found that the methionine concentration in the hemolymph is lower in flies that bear tumors in the wing disc, which is reminiscent of the clinical condition where tumor affects the amino acid profiles in the blood (<xref ref-type="bibr" rid="bib29">Lai et al., 2005</xref>). Of note, local glutamine is known to be consumed in the tumor environment (<xref ref-type="bibr" rid="bib49">Sanderson et al., 2019</xref>), but at least we did not observe reduction of glutamine in the hemolymph of the flies bearing tumors. We presume that Src-induced increase of methionine uptake in the Src tumor is at least partly responsible for the Src tumor-induced hypomethioninemia, although other tissues may also contribute to it as the case of the fat body during wing disc repair (<xref ref-type="bibr" rid="bib24">Kashio et al., 2016</xref>).</p><p>Regarding a cross-talk between Src signaling and nutrition-mediated Tor activation, we found that there are multiple cross-talk points. Src regulates methionine uptake and methionine flux in a p38-independent manner, both of which can potentially feed into Tor activation. Then, a question is how Src-p38 regulates Tor signaling, since Src-p38 clearly activates Tor signaling (<xref ref-type="fig" rid="fig5">Figure 5A–B</xref>). Although p38 is known to regulate Tor, its exact molecular mechanism remains unclear (<xref ref-type="bibr" rid="bib6">Cully et al., 2010</xref>). Using the previously published RNAseq data on Src tumor in the wing disc (<xref ref-type="bibr" rid="bib19">Ho et al., 2015</xref>), we surveyed expression levels of potential Tor regulators and selected genes that are affected by <italic>Src</italic> expression, including amino acid transporters and GATOR complexes. GATOR complexes regulate Tor through Rag GTPases (<xref ref-type="bibr" rid="bib26">Kim and Guan, 2019</xref>; <xref ref-type="bibr" rid="bib48">Sabatini, 2017</xref>). We examined whether their expression is regulated by Src in a p38-dependent manner using RT-qPCR. We found that among the amino acid transporters and GATOR complex components examined, only <italic>pathetic</italic> (<italic>path</italic>), an SLC36 amino acid transporter that can transport multiple amino acids, was significantly induced by Src in a p38-dependent manner (<xref ref-type="fig" rid="fig8s1">Figure 8—figure supplement 1E, F</xref>). Since Path can mediate amino acids-mediated Tor activation (<xref ref-type="bibr" rid="bib14">Goberdhan et al., 2005</xref>; <xref ref-type="bibr" rid="bib36">Newton et al., 2020</xref>), we speculate that Src-p38 could regulate Tor potentially through Path-mediated uptake of non-methionine amino acids.</p><p>Our findings have significant implications in the field of cancer therapeutics. As described in Introduction, SFK inhibitors have been clinically unsuccessful in spite of SFKs’ contribution to tumorigenesis and metastasis (<xref ref-type="bibr" rid="bib13">Gargalionis et al., 2014</xref>; <xref ref-type="bibr" rid="bib58">Sousa-Victor and Jasper, 2014</xref>). We expect that the new insights our study provides on the Src tumorigenesis may help pave the way to cancer treatment. Furthermore, our data imply that nutritional state and tumorigenesis are closely linked. We speculate that, in case of tumors with a high SFK activity, manipulation of dietary methionine may have a clinical benefit.</p></sec><sec id="s4" sec-type="materials|methods"><title>Materials and methods</title><table-wrap id="keyresource" position="anchor"><label>Key resources table</label><table frame="hsides" rules="groups"><thead><tr><th valign="top">Reagent type (species) or resource</th><th valign="top">Designation</th><th valign="top">Source or reference</th><th valign="top">Identifiers</th><th valign="top">Additional information</th></tr></thead><tbody><tr><td valign="top">Gene <italic>Drosophila melanogaster</italic></td><td valign="top">ras</td><td valign="top">Flybase</td><td valign="top">FLYB: FBgn0003205</td><td valign="top">NA</td></tr><tr><td valign="top">Gene <italic>Drosophila melanogaster</italic></td><td valign="top">src42A</td><td valign="top">Flybase</td><td valign="top">FLYB: FBgn0264959</td><td valign="top">NA</td></tr><tr><td valign="top">Gene <italic>Drosophila melanogaster</italic></td><td valign="top">vg</td><td valign="top">Flybase</td><td valign="top">FLYB: FBgn0003975</td><td valign="top">NA</td></tr><tr><td valign="top">Gene <italic>Drosophila melanogaster</italic></td><td valign="top">slpr</td><td valign="top">Flybase</td><td valign="top">FLYB: FBgn0030018</td><td valign="top">NA</td></tr><tr><td valign="top">Gene <italic>Drosophila melanogaster</italic></td><td valign="top">rpr</td><td valign="top">Flybase</td><td valign="top">FLYB: FBgn0011706</td><td valign="top">NA</td></tr><tr><td valign="top">Gene <italic>Drosophila melanogaster</italic></td><td valign="top">grim</td><td valign="top">Flybase</td><td valign="top">FLYB: FBgn0015946</td><td valign="top">NA</td></tr><tr><td valign="top">Gene <italic>Drosophila melanogaster</italic></td><td valign="top">hid</td><td valign="top">Flybase</td><td valign="top">FLYB: FBgn0003997</td><td valign="top">NA</td></tr><tr><td valign="top">Gene <italic>Drosophila melanogaster</italic></td><td valign="top">bsk</td><td valign="top">Flybase</td><td valign="top">FLYB: FBgn0000229</td><td valign="top">NA</td></tr><tr><td valign="top">Gene <italic>Drosophila melanogaster</italic></td><td valign="top">lic</td><td valign="top">Flybase</td><td valign="top">FLYB: FBgn0261524</td><td valign="top">NA</td></tr><tr><td valign="top">Gene <italic>Drosophila melanogaster</italic></td><td valign="top">tor</td><td valign="top">Flybase</td><td valign="top">FLYB: FBgn0021796</td><td valign="top">NA</td></tr><tr><td valign="top">Gene <italic>Drosophila melanogaster</italic></td><td valign="top">rl</td><td valign="top">Flybase</td><td valign="top">FLYB: FBgn0003256</td><td valign="top">NA</td></tr><tr><td valign="top">Gene <italic>Drosophila melanogaster</italic></td><td valign="top">p38b</td><td valign="top">Flybase</td><td valign="top">FLYB: FBgn0024846</td><td valign="top">NA</td></tr><tr><td valign="top">Gene <italic>Drosophila melanogaster</italic></td><td valign="top">mef2</td><td valign="top">Flybase</td><td valign="top">FLYB: FBgn0003256</td><td valign="top">NA</td></tr><tr><td valign="top">Gene <italic>Drosophila melanogaster</italic></td><td valign="top">atf2</td><td valign="top">Flybase</td><td valign="top">FLYB: FBgn0265193</td><td valign="top">NA</td></tr><tr><td valign="top">Gene <italic>Drosophila melanogaster</italic></td><td valign="top">SamS</td><td valign="top">Flybase</td><td valign="top">FLYB: FBgn0005278</td><td valign="top">NA</td></tr><tr><td valign="top">Gene <italic>Drosophila melanogaster</italic></td><td valign="top">samtor</td><td valign="top">Flybase</td><td valign="top">FLYB: FBgn0035035</td><td valign="top">NA</td></tr><tr><td valign="top">Gene <italic>Drosophila melanogaster</italic></td><td valign="top">CG13248</td><td valign="top">Flybase</td><td valign="top">FLYB: FBgn0036984</td><td valign="top">NA</td></tr><tr><td valign="top">Gene <italic>Drosophila melanogaster</italic></td><td valign="top">tadr</td><td valign="top">Flybase</td><td valign="top">FLYB: FBgn0036984</td><td valign="top">NA</td></tr><tr><td valign="top">Gene <italic>Drosophila melanogaster</italic></td><td valign="top">CG9413</td><td valign="top">Flybase</td><td valign="top">FLYB: FBgn0030574</td><td valign="top">NA</td></tr><tr><td valign="top">Gene <italic>Drosophila melanogaster</italic></td><td valign="top">jhl-21</td><td valign="top">Flybase</td><td valign="top">FLYB: FBgn0028425</td><td valign="top">NA</td></tr><tr><td valign="top">Gene <italic>Drosophila melanogaster</italic></td><td valign="top">sbm</td><td valign="top">Flybase</td><td valign="top">FLYB: FBgn0030574</td><td valign="top">NA</td></tr><tr><td valign="top">Gene <italic>Drosophila melanogaster</italic></td><td valign="top">CG8757</td><td valign="top">Flybase</td><td valign="top">FLYB: FBgn0036380</td><td valign="top">NA</td></tr><tr><td valign="top">Gene <italic>Drosophila melanogaster</italic></td><td valign="top">CG16700</td><td valign="top">Flybase</td><td valign="top">FLYB: FBgn0030816</td><td valign="top">NA</td></tr><tr><td valign="top">Gene <italic>Drosophila melanogaster</italic></td><td valign="top">path</td><td valign="top">Flybase</td><td valign="top">FLYB: FBgn0036007</td><td valign="top">NA</td></tr><tr><td valign="top">Gene <italic>Drosophila melanogaster</italic></td><td valign="top">nprl3</td><td valign="top">Flybase</td><td valign="top">FLYB: FBgn0036397</td><td valign="top">NA</td></tr><tr><td valign="top">Gene <italic>Drosophila melanogaster</italic></td><td valign="top">nprl2</td><td valign="top">Flybase</td><td valign="top">FLYB: FBgn0030800</td><td valign="top">NA</td></tr><tr><td valign="top">Gene <italic>Drosophila melanogaster</italic></td><td valign="top">iml1</td><td valign="top">Flybase</td><td valign="top">FLYB: FBgn0035227</td><td valign="top">NA</td></tr><tr><td valign="top">Gene <italic>Drosophila melanogaster</italic></td><td valign="top">wdr24</td><td valign="top">Flybase</td><td valign="top">FLYB: FBgn0027518</td><td valign="top">NA</td></tr><tr><td valign="top">Gene <italic>Drosophila melanogaster</italic></td><td valign="top">wdr59</td><td valign="top">Flybase</td><td valign="top">FLYB: FBgn0032339</td><td valign="top">NA</td></tr><tr><td valign="top">Gene <italic>Drosophila melanogaster</italic></td><td valign="top">nup44A</td><td valign="top">Flybase</td><td valign="top">FLYB: FBgn0033247</td><td valign="top">NA</td></tr><tr><td valign="top">Gene <italic>Drosophila melanogaster</italic></td><td valign="top">mio</td><td valign="top">Flybase</td><td valign="top">FLYB: FBgn0031399</td><td valign="top">NA</td></tr><tr><td valign="top">Gene <italic>Drosophila melanogaster</italic></td><td valign="top">RpL32</td><td valign="top">Flybase</td><td valign="top">FLYB: FBgn0002626</td><td valign="top">NA</td></tr><tr><td valign="top">Genetic reagent (<italic>Drosophila melanogaster</italic>)</td><td valign="top">UAS-RasV12</td><td valign="top">Iswar Hariharan lab</td><td valign="top">UAS-RasV12</td><td valign="top">NA</td></tr><tr><td valign="top">Genetic reagent (<italic>Drosophila melanogaster</italic>)</td><td valign="top">UAS-Src42A CA</td><td valign="top">Bloomington <italic>Drosophila</italic> Stock Center</td><td valign="top">BDSC: 6410 <break/>RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:BDSC_6410">BDSC_6410</ext-link></td><td valign="top">NA</td></tr><tr><td valign="top">Genetic reagent (<italic>Drosophila melanogaster</italic>)</td><td valign="top">UAS-Src42A</td><td valign="top">Tian Xu lab</td><td valign="top">UAS-Src42A</td><td valign="top">NA</td></tr><tr><td valign="top">Genetic reagent (<italic>Drosophila melanogaster</italic>)</td><td valign="top">vg-Gal4</td><td valign="top">Bloomington <italic>Drosophila</italic> Stock Center</td><td valign="top">BDSC: 6819 <break/>RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:BDSC_6819">BDSC_6819</ext-link></td><td valign="top">NA</td></tr><tr><td valign="top">Genetic reagent (<italic>Drosophila melanogaster</italic>)</td><td valign="top">gmr-Gal4</td><td valign="top">Iswar Hariharan lab</td><td valign="top">gmr-Gal4</td><td valign="top">NA</td></tr><tr><td valign="top">Genetic reagent (<italic>Drosophila melanogaster</italic>)</td><td valign="top">TRE-RFP</td><td valign="top">Bloomington <italic>Drosophila</italic> Stock Center</td><td valign="top">BDSC: 59011</td><td valign="top">NA</td></tr><tr><td valign="top">Genetic reagent (<italic>Drosophila melanogaster</italic>)</td><td valign="top">UAS-slpr RNAi</td><td valign="top">Bloomington <italic>Drosophila</italic> Stock Center</td><td valign="top">BDSC: 32948 <break/>RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:BDSC_32948">BDSC_32948</ext-link></td><td valign="top">NA</td></tr><tr><td valign="top">Genetic reagent (<italic>Drosophila melanogaster</italic>)</td><td valign="top">UAS-slpr RNAi</td><td valign="top">Vienna <italic>Drosophila</italic> Resource Center</td><td valign="top">VDRC ID: 33516 <break/>RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:FlyBase_FBst0460140">FlyBase_FBst0460140</ext-link></td><td valign="top">NA</td></tr><tr><td valign="top">Genetic reagent (<italic>Drosophila melanogaster</italic>)</td><td valign="top">UAS-GFP</td><td valign="top">Iswar Hariharan lab</td><td valign="top">UAS-GFP</td><td valign="top">NA</td></tr><tr><td valign="top">Genetic reagent (<italic>Drosophila melanogaster</italic>)</td><td valign="top">UAS-his2B RFP</td><td valign="top">Iswar Hariharan lab</td><td valign="top">UAS-his2B RFP</td><td valign="top">NA</td></tr><tr><td valign="top">Genetic reagent (<italic>Drosophila melanogaster</italic>)</td><td valign="top">UAS-miRNA RGH</td><td valign="top"><xref ref-type="bibr" rid="bib54">Siegrist et al., 2010</xref></td><td valign="top">PMID:<ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/pubmed/20346676">20346676</ext-link></td><td valign="top">NA</td></tr><tr><td valign="top">Genetic reagent (<italic>Drosophila melanogaster</italic>)</td><td valign="top">UAS-JNK DN</td><td valign="top">Iswar Hariharan lab</td><td valign="top">UAS-JNK DN</td><td valign="top">NA</td></tr><tr><td valign="top">Genetic reagent (<italic>Drosophila melanogaster</italic>)</td><td valign="top">UAS-p38 DN</td><td valign="top">Bloomington <italic>Drosophila</italic> Stock Center</td><td valign="top">BDSC: 59005 <break/>RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:BDSC_59005">BDSC_59005</ext-link></td><td valign="top">NA</td></tr><tr><td valign="top">Genetic reagent (<italic>Drosophila melanogaster</italic>)</td><td valign="top">UAS-lic RNAi</td><td valign="top">Bloomington <italic>Drosophila</italic> Stock Center</td><td valign="top">BDSC: 31643 <break/>RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:BDSC_31643">BDSC_31643</ext-link></td><td valign="top">NA</td></tr><tr><td valign="top">Genetic reagent (<italic>Drosophila melanogaster</italic>)</td><td valign="top">UAS-Tor RNAi</td><td valign="top">Bloomington <italic>Drosophila</italic> Stock Center</td><td valign="top">BDSC: 34639 <break/>RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:BDSC_34639">BDSC_34639</ext-link></td><td valign="top">NA</td></tr><tr><td valign="top">Genetic reagent (<italic>Drosophila melanogaster</italic>)</td><td valign="top">UAS-erk RNAi 1</td><td valign="top">Vienna <italic>Drosophila</italic> Resource Center</td><td valign="top">VDRC ID: 35641 <break/>RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:FlyBase_FBst0461260">FlyBase_FBst0461260</ext-link></td><td valign="top">NA</td></tr><tr><td valign="top">Genetic reagent (<italic>Drosophila melanogaster</italic>)</td><td valign="top">UAS-erk RNAi 2</td><td valign="top">Vienna <italic>Drosophila</italic> Resource Center</td><td valign="top">VDRC ID: 109573 <break/>RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:FlyBase_FBst0481239">FlyBase_FBst0481239</ext-link></td><td valign="top">NA</td></tr><tr><td valign="top">Genetic reagent (<italic>Drosophila melanogaster</italic>)</td><td valign="top">UAS-mef2 RNAi</td><td valign="top">Vienna <italic>Drosophila</italic> Resource Center</td><td valign="top">VDRC ID: 15550 <break/>RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:FlyBase_FBst0451917">FlyBase_FBst0451917</ext-link></td><td valign="top">NA</td></tr><tr><td valign="top">Genetic reagent (<italic>Drosophila melanogaster</italic>)</td><td valign="top">UAS-atf2 RNAi</td><td valign="top">Bloomington <italic>Drosophila</italic> Stock Center</td><td valign="top">BDSC: 60124 <break/>RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:BDSC_60124">BDSC_60124</ext-link></td><td valign="top">NA</td></tr><tr><td valign="top">Genetic reagent (<italic>Drosophila melanogaster</italic>)</td><td valign="top">UAS-SamS RNAi 1</td><td valign="top">Vienna <italic>Drosophila</italic> Resource Center</td><td valign="top">VDRC ID: 7167 <break/>RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:FlyBase_FBst0470579">FlyBase_FBst0470579</ext-link></td><td valign="top">NA</td></tr><tr><td valign="top">Genetic reagent (<italic>Drosophila melanogaster</italic>)</td><td valign="top">UAS-SamS RNAi 2</td><td valign="top">Vienna <italic>Drosophila</italic> Resource Center</td><td valign="top">VDRC ID: 103143 <break/>RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:FlyBase_FBst0475005">FlyBase_FBst0475005</ext-link></td><td valign="top">NA</td></tr><tr><td valign="top">Genetic reagent (<italic>Drosophila melanogaster</italic>)</td><td valign="top">UAS-samtor RNAi</td><td valign="top">Bloomington <italic>Drosophila</italic> Stock Center</td><td valign="top">BDSC: 54010 <break/>RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:BDSC_54010">BDSC_54010</ext-link></td><td valign="top">NA</td></tr><tr><td valign="top">Genetic reagent (<italic>Drosophila melanogaster</italic>)</td><td valign="top">UAS-eiger</td><td valign="top">Iswar Hariharan lab</td><td valign="top">UAS-eiger</td><td valign="top">NA</td></tr><tr><td valign="top">Genetic reagent (<italic>Drosophila melanogaster</italic>)</td><td valign="top">UAS-rpr mts</td><td valign="top">Herman Steller lab</td><td valign="top">PMID:<ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/pubmed/20837774">20837774</ext-link></td><td valign="top">NA</td></tr><tr><td valign="top">Genetic reagent (<italic>Drosophila melanogaster</italic>)</td><td valign="top">w¹¹¹⁸</td><td valign="top">Erina Kuranaga lab</td><td valign="top">w¹¹¹⁸</td><td valign="top">NA</td></tr><tr><td valign="top">Genetic reagent (<italic>Drosophila melanogaster</italic>)</td><td valign="top">Oregon R</td><td valign="top">Bloomington <italic>Drosophila</italic> Stock Center</td><td valign="top">BDSC: 4269 <break/>RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:BDSC_4269">BDSC_4269</ext-link></td><td valign="top">NA</td></tr><tr><td valign="top">Antibody</td><td valign="top">Rabbit polyclonal phospho H3 antibody</td><td valign="top">Merck</td><td valign="top">Cat# 06–570 <break/>RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_310177">AB_310177</ext-link></td><td valign="top">Immunostaining (1:200)</td></tr><tr><td valign="top">Antibody</td><td valign="top">Rabbit polyclonal cleaved <italic>Drosophila</italic> Dcp-1 antibody</td><td valign="top">Cell Signaling</td><td valign="top">Cat# 9578 <break/>RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_2721060">AB_2721060</ext-link></td><td valign="top">Immunostaining (1:100)</td></tr><tr><td valign="top">Antibody</td><td valign="top">Rabbit monoclonal phospho-p38 MAPK antibody</td><td valign="top">Cell Signaling</td><td valign="top">Cat# 4631 <break/>RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_331765">AB_331765</ext-link></td><td valign="top">Immunostaining (1:100)</td></tr><tr><td valign="top">Antibody</td><td valign="top">Mouse monoclonal phospho-Erk MAPK antibody</td><td valign="top">Merck</td><td valign="top">Cat# M8159 <break/>RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_477245">AB_477245</ext-link></td><td valign="top">Immunostaining (1:100)</td></tr><tr><td valign="top">Antibody</td><td valign="top">Rabbit monoclonal phospho-4EBP1 antibody</td><td valign="top">Cell Signaling</td><td valign="top">Cat# 2855 <break/>RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_560835">AB_560835</ext-link></td><td valign="top">Immunostaining (1:100)</td></tr><tr><td valign="top">Antibody</td><td valign="top">Rabbit polyclonal phospho-S6 antibody</td><td valign="top"><xref ref-type="bibr" rid="bib25">Kim et al., 2017</xref></td><td valign="top">PMID:<ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/pubmed/28829944">28829944</ext-link></td><td valign="top">Immunostaining (1:300)</td></tr><tr><td valign="top">Antibody</td><td valign="top">Alexa mouse Fluor 568 secondary antibody</td><td valign="top">Thermo Fisher</td><td valign="top">Cat# A-11004 <break/>RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_253407">AB_253407</ext-link></td><td valign="top">Immunostaining (1:300)</td></tr><tr><td valign="top">Antibody</td><td valign="top">Alexa rabbit Fluor 568 secondary antibody</td><td valign="top">Thermo Fisher</td><td valign="top">A-11036 <break/>RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_10563566">AB_10563566</ext-link></td><td valign="top">Immunostaining (1:300)</td></tr><tr><td valign="top">Sequence-based reagent</td><td valign="top">slpr (primer)</td><td valign="top">This paper</td><td valign="top">NA</td><td valign="top">F: 5'-<named-content content-type="sequence">CTACAAGGGCTTCGATCCGTTG</named-content>-3 <break/>R: 5'-<named-content content-type="sequence">GTTTGCCAGCAGCTCTTCATCAG</named-content>-3</td></tr><tr><td valign="top">Sequence-based reagent</td><td valign="top">slpr (primer)</td><td valign="top">This paper</td><td valign="top">NA</td><td valign="top">F: 5'-<named-content content-type="sequence">CAATCATCTGCAGCAGAAGACGC</named-content>-3' <break/>R: 5'-<named-content content-type="sequence">CATCGGAGAATTTGGAATAGGTGC</named-content>-3'</td></tr><tr><td valign="top">Sequence-based reagent</td><td valign="top">SamS (primer)</td><td valign="top"><xref ref-type="bibr" rid="bib38">Obata and Miura, 2015</xref></td><td valign="top">PMID:<ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/pubmed/32938923">32938923</ext-link></td><td valign="top">F: 5'-<named-content content-type="sequence">GCCAACGGCGTTCATATC</named-content>-3' <break/>R: 5'-<named-content content-type="sequence">GGCATATCCAAACATGATACCC</named-content>-3'</td></tr><tr><td valign="top">Sequence-based reagent</td><td valign="top">CG13248 (primer)</td><td valign="top">FlyPrimerBank</td><td valign="top">PP18106</td><td valign="top">F: 5'-<named-content content-type="sequence">AAACCGATGCCTCAACACCTT</named-content>-3' <break/>R: 5'-<named-content content-type="sequence">CAGTCAGCACGTAGATGCCA</named-content>-3'</td></tr><tr><td valign="top">Sequence-based reagent</td><td valign="top">tadr (primer)</td><td valign="top">FlyPrimerBank</td><td valign="top">PP20579</td><td valign="top">F: 5'-<named-content content-type="sequence">CAGCCCGCTGTAAAACTAGC</named-content>-3' <break/>R: 5'-<named-content content-type="sequence">GGCCAGAGCATCTAGCCAG</named-content>-3'</td></tr><tr><td valign="top">Sequence-based reagent</td><td valign="top">CG9413 (primer)</td><td valign="top">FlyPrimerBank</td><td valign="top">PP29104</td><td valign="top">F: 5'-<named-content content-type="sequence">TGGGGTGGCTTTAATTGTTGG</named-content>-3' <break/>R: 5'-<named-content content-type="sequence">CAGTGCGAACCAGTAAACCG</named-content>-3'</td></tr><tr><td valign="top">Sequence-based reagent</td><td valign="top">jhl-21 (primer)</td><td valign="top"><xref ref-type="bibr" rid="bib36">Newton et al., 2020</xref></td><td valign="top">PMID:<ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/pubmed/32938923">32938923</ext-link></td><td valign="top">F: 5'-<named-content content-type="sequence">TCAAGCGGAAGCTAACACTCA</named-content>-3' <break/>R: 5'-<named-content content-type="sequence">TTCGGTGTAAATAAAGACTCCCG</named-content>-3'</td></tr><tr><td valign="top">Sequence-based reagent</td><td valign="top">sbm (primer)</td><td valign="top">FlyPrimerBank</td><td valign="top">PP3597</td><td valign="top">F: 5'-<named-content content-type="sequence">AATGTGCCAACAAAAACAACGA</named-content>-3' <break/>R: 5'-<named-content content-type="sequence">GTCCCTGATGAGTCGGTCTC</named-content>-3'</td></tr><tr><td valign="top">Sequence-based reagent</td><td valign="top">CG8757 (primer)</td><td valign="top"><xref ref-type="bibr" rid="bib36">Newton et al., 2020</xref></td><td valign="top">PMID:<ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/pubmed/32938923">32938923</ext-link></td><td valign="top">F: 5'-<named-content content-type="sequence">AGAAACGATTGGATCGGGCA</named-content>-3' <break/>R: 5'-<named-content content-type="sequence">ATCTGCCATCTTTTGGACCGA</named-content>-3'</td></tr><tr><td valign="top">Sequence-based reagent</td><td valign="top">CG16700 (primer)</td><td valign="top">FlyPrimerBank</td><td valign="top">PP25676</td><td valign="top">F: 5'-<named-content content-type="sequence">CCTACAAGCTATCTGGAGACCA</named-content>-3' <break/>R: 5'-<named-content content-type="sequence">GAGACCTCCGTTCTTGAAGGC</named-content>-3'</td></tr><tr><td valign="top">Sequence-based reagent</td><td valign="top">path (primer)</td><td valign="top"><xref ref-type="bibr" rid="bib36">Newton et al., 2020</xref></td><td valign="top">PMID:<ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/pubmed/32938923">32938923</ext-link></td><td valign="top">F: 5'-<named-content content-type="sequence">TGTTTGATTTGCGCGGCATT</named-content>-3' <break/>R: 5'-<named-content content-type="sequence">TTCGACCCGCTGTCCACTAT</named-content>-3'</td></tr><tr><td valign="top">Sequence-based reagent</td><td valign="top">nprl3 (primer)</td><td valign="top">FlyPrimerBank</td><td valign="top">PP28256</td><td valign="top">F: 5'-<named-content content-type="sequence">GTTAAACCACAGCTATGCAACCA</named-content>-3' <break/>R: 5'-<named-content content-type="sequence">CAGAGTGGGATGACTGACAAAG</named-content>-3'</td></tr><tr><td valign="top">Sequence-based reagent</td><td valign="top">nprl2 (primer)</td><td valign="top">FlyPrimerBank</td><td valign="top">PP27923</td><td valign="top">F: 5'-<named-content content-type="sequence">TTCAACGCTGCATTCTCACC</named-content>-3' <break/>R: 5'-<named-content content-type="sequence">ATTCCGTGCGTACTTCTGCTG</named-content>-3'</td></tr><tr><td valign="top">Sequence-based reagent</td><td valign="top">iml1 (primer)</td><td valign="top">FlyPrimerBank</td><td valign="top">PP8389</td><td valign="top">F: 5'-<named-content content-type="sequence">CGTGGCTGCAACAAATCCTAC</named-content>-3' <break/>R: 5'-<named-content content-type="sequence">GCCCGATTCTATGCTTATCACA</named-content>-3'</td></tr><tr><td valign="top">Sequence-based reagent</td><td valign="top">wdr24 (primer)</td><td valign="top">FlyPrimerBank</td><td valign="top">PP3395</td><td valign="top">F: 5'-<named-content content-type="sequence">GCCCTGGCCCTGAATAAGG</named-content>-3' <break/>R: 5'-<named-content content-type="sequence">TGAAGCCATTGCTGTTTATGGAG</named-content>-3'</td></tr><tr><td valign="top">Sequence-based reagent</td><td valign="top">wdr59 (primer)</td><td valign="top">FlyPrimerBank</td><td valign="top">PP2977</td><td valign="top">F: 5'-<named-content content-type="sequence">GCACCCGAACAAACGTACATC</named-content>-3' <break/>R: 5'-<named-content content-type="sequence">CCGAGTAATCAACCGACATGG</named-content>-3'</td></tr><tr><td valign="top">Sequence-based reagent</td><td valign="top">nup44A (primer)</td><td valign="top">FlyPrimerBank</td><td valign="top">PP28620</td><td valign="top">F: 5'-<named-content content-type="sequence">GAGGAGGTGATTGGCGAAAAG</named-content>-3'' <break/>R: 5'-<named-content content-type="sequence">GCGAGTCTACAAGGGTGGTG</named-content>-3'</td></tr><tr><td valign="top">Sequence-based reagent</td><td valign="top">mio (primer)</td><td valign="top">NA</td><td valign="top">PMID:<ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/pubmed/26024590">26024590</ext-link></td><td valign="top">F: 5'-<named-content content-type="sequence">AGCGAGACGAGCTAAACAATTC</named-content>-3' <break/>R: 5'-<named-content content-type="sequence">GTGTAAGAGGCAAGCAAAGGTT</named-content>-3'</td></tr><tr><td valign="top">Sequence-based reagent</td><td valign="top">RpL32 (primer)</td><td valign="top">This paper</td><td valign="top">NA</td><td valign="top">F: 5'-<named-content content-type="sequence">CCAGCATACAGGCCCAAGATCGTG</named-content>-3' <break/>R: 5'-<named-content content-type="sequence">TCTTGAATCCGGTGGGCAGCATG</named-content>-3'</td></tr><tr><td valign="top">Commercial assay or kit</td><td valign="top">Methionine analog homopropargylglycine (HPG)- based on Click-iT HPG Alexa Fluor 488 Protein Synthesis Assay kit Single Cell 3’ Library and Gel Bead Kit v2</td><td valign="top">Invitrogen</td><td valign="top">C10428</td><td valign="top">NA</td></tr><tr><td valign="top">Commercial assay or kit</td><td valign="top">Maxwell RSC simply RNA Tissue Kit</td><td valign="top">Promega</td><td valign="top">AS1340</td><td valign="top">NA</td></tr><tr><td valign="top">Commercial assay or kit</td><td valign="top">ReverTra Ace qPCR RT Kit</td><td valign="top">Toyobo</td><td valign="top">FSQ-101</td><td valign="top">NA</td></tr><tr><td valign="top">Commercial assay or kit</td><td valign="top">BCA protein assay kit</td><td valign="top">Thermo Fisher</td><td valign="top">23225</td><td valign="top">NA</td></tr><tr><td valign="top">Software, algorithm</td><td valign="top">ImageJ</td><td valign="top">NA</td><td valign="top"><ext-link ext-link-type="uri" xlink:href="https://imagej.nih.gov/ij/">https://imagej.nih.gov/ij/</ext-link> RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:SCR_003070">SCR_003070</ext-link></td><td valign="top">NA</td></tr><tr><td valign="top">Software, algorithm</td><td valign="top">IMARIS 9.5.1</td><td valign="top">Oxford Instrument</td><td valign="top"><ext-link ext-link-type="uri" xlink:href="https://imaris.oxinst.com/packages">https://imaris.oxinst.com/packages</ext-link> <break/>RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:SCR_007370">SCR_007370</ext-link></td><td valign="top">NA</td></tr><tr><td valign="top">Other</td><td valign="top">DAPI</td><td valign="top">Sigma</td><td valign="top">D9542</td><td valign="top">1:1000</td></tr></tbody></table></table-wrap><sec id="s4-1"><title><italic>Drosophila</italic> husbandry</title><p>Flies were maintained as previously described (<xref ref-type="bibr" rid="bib69">Yoo et al., 2016</xref>). The fly food is composed of the following ingredients: 0.8% agar, 10% glucose, 4.5% corn flour, 3.72% dry yeast, 0.4% propionic acid, 0.3% butyl <italic>p</italic>-hydroxybenzoate.</p><p>The composition of the food for yeast restriction and amino acid addition/subtraction is described in <xref ref-type="supplementary-material" rid="supp1">Supplementary file 1</xref> and <xref ref-type="supplementary-material" rid="supp2">Supplementary file 2</xref>. The amino acid concentrations are based on the previously described holidic medium for <italic>Drosophila melanogaster</italic> (<xref ref-type="bibr" rid="bib42">Piper et al., 2014</xref>).</p></sec><sec id="s4-2"><title><italic>Drosophila</italic> stocks</title><p>Flies were crossed and raised at 25°C unless otherwise noted. For wild-type controls, Oregon-R (Bloomington stock center [BL] 4269) was used. The following fly stocks were used in this study:</p><list list-type="bullet"><list-item><p><italic>UAS-Src42A CA</italic> (BL6410)</p></list-item><list-item><p><italic>UAS-Src42A</italic> (a gift from Dr Tian Xu) <italic>vg-Gal4</italic> (BL6819) <italic>gmr-Gal4</italic> (a gift from Dr Iswar Hariharan)</p></list-item><list-item><p><italic>TRE-RFP</italic> (a gift from Dr Dirk Bohmann)</p></list-item><list-item><p><italic>UAS-slpr RNAi</italic> (BL32948, v33516)</p></list-item><list-item><p><italic>UAS-GFP</italic> (a gift from Dr Iswar Hariharan)</p></list-item><list-item><p><italic>UAS-his2B RFP</italic> (a gift from Dr Iswar Hariharan)</p></list-item><list-item><p><italic>UAS-miRNA RGH</italic> (a gift from Dr Iswar Hariharan)</p></list-item><list-item><p><italic>UAS-JNK DN</italic> (a gift from Dr Iswar Hariharan)</p></list-item><list-item><p><italic>UAS-p38 DN</italic> (BL59005)</p></list-item><list-item><p><italic>UAS-lic RNAi</italic> (BL31643)</p></list-item><list-item><p><italic>UAS-Tor RNAi</italic> (BL34639)</p></list-item><list-item><p><italic>UAS-erk RNAi</italic> (RNAi 1: v35641, RNAi 2: v109573)</p></list-item><list-item><p><italic>UAS-RasV12</italic> (a gift from Dr Iswar Hariharan)</p></list-item><list-item><p><italic>UAS-mef2 RNAi</italic> (v15550)</p></list-item><list-item><p><italic>UAS-atf2 RNAi</italic> (BL60124)</p></list-item><list-item><p><italic>UAS-SamS RNAi</italic> (RNAi 1: v7167, RNAi 2: v103143)</p></list-item><list-item><p><italic>UAS-samtor RNAi</italic> (BL54010)</p></list-item><list-item><p><italic>UAS-rpr<sup>mts</sup></italic> (a gift from Hermann Steller) (<xref ref-type="bibr" rid="bib50">Sandu et al., 2010</xref>)</p></list-item><list-item><p><italic>UAS-eiger</italic> (a gift from Dr Iswar Hariharan) <italic>w<sup>1118</sup></italic> (a gift from Dr Erina Kuranaga)</p></list-item></list></sec><sec id="s4-3"><title>Immunofluorescence and confocal imaging</title><p>Wing discs were dissected in PBS, fixed with paraformaldehyde in PBS, and washed in PBS with 0.1% Triton X-100. We used the following antibodies and fluorescent dyes: rabbit phospho H3 antibody (1:200, 06–570, Merck), rabbit cleaved <italic>Drosophila</italic> Dcp-1 antibody (1:100, #9578, Cell Signaling), rabbit phospho-p38 MAPK antibody (1:100, #4631, Cell Signaling), mouse phospho-Erk MAPK antibody (1:100, M8159, Merck), rabbit phosphor-4EBP one antibody (1:100, #2855, Cell Signaling), rabbit phospho-S6 antibody (1:300) (<xref ref-type="bibr" rid="bib25">Kim et al., 2017</xref>), DAPI (D9542, Sigma), and Alexa Fluor secondary antibodies (A11004, A11008). Fluorescent images were acquired with confocal microscopes (Zeiss LSM 880,780). Quantification of the cell volume and the intensity measurement of fluorescent signals were performed by using IMARIS 9.5.1. ImageJ was used to measure the wing size.</p></sec><sec id="s4-4"><title>Immunostaining quantification</title><p>For quantification of the fluorescent intensity for TRE-RFP, p-p38, pERK, p4EBP, and pS6 in GFP+ cells, GFP+ cell volume and sum intensity of fluorescent signals in GFP+ cells were used. Samples were analyzed with IMARIS 9.5.1. The GFP intensity was measured to identify GFP+ cells. The volume and the sum intensity of fluorescent signals were quantified by surface function. The mean intensity within GFP+ cells was calculated by dividing the sum intensity of fluorescent signals by GFP+ cell volume. For quantification of the fluorescent intensity in GFP- cells, the total disc size (μm<sup>3</sup>) and the sum intensity of fluorescent signals within the whole disc were measured. DAPI intensity was used to determine the whole disc region. Volume of GFP- cells and sum intensity in GFP- cells were quantified by subtracting each information (volume, sum intensity) in GFP+ cells from ones in whole discs. The mean intensity of fluorescence within GFP- cells was calculated as performed in GFP+ cells.</p></sec><sec id="s4-5"><title>Quantification of proliferating cells</title><p>For quantification of proliferation rate, the number of pH3-positive cells and GFP+ cell area were measured by using ImageJ. The density of pH3+ cells was calculated by dividing the number of pH3+ cells by GFP+ cell area.</p></sec><sec id="s4-6"><title>Quantification of dying cells</title><p>To determine the dying cells, the intensity of cDCP1 antibody staining was used. Percentage of DCP1-positive cells was measured in GFP+/- cells respectively by using ImageJ.</p></sec><sec id="s4-7"><title>Measurement of survival rate</title><p>For measuring the survival rate, mated females were allowed to lay eggs on a grape agar plate for 24 hr at 25°C. First instar larvae were collected from the grape agar plate and placed into treatment vials with different food conditions. Each vial contains 50 larvae. The number of adult flies of each genotype that were able to eclose was recorded. Survival rates were calculated as the number of adult flies that eclosed divided by the expected number of larvae of each genotype placed in each vial. Most experiments were performed at 25°C, except the ones performed at 23°C to increase the sensitivity of the assays in Figures 2A, 3E, 4F, 6E and 7A–C, <xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1H</xref> and <xref ref-type="fig" rid="fig7s1">Figure 7—figure supplement 1A–B</xref>.</p></sec><sec id="s4-8"><title>Measurement of amino acids in the larval hemolymph</title><p>We teared 20 L3 larvae on an iced block to collect 5 µl of the hemolymph. Extraction and quantification of metabolites in the hemolymph were performed as described previously with capillary electrophoresis time-of-flight mass spectrometry (<xref ref-type="bibr" rid="bib57">Soga et al., 2006</xref>; <xref ref-type="bibr" rid="bib56">Soga et al., 2003</xref>; <xref ref-type="bibr" rid="bib61">Tabata et al., 2017</xref>).</p></sec><sec id="s4-9"><title>Measurement of methionine and SAM in the larval wing discs and hemolymph by LC-MS/MS</title><p>Twenty wing discs or 1.5 µl hemolymph were used per sample to measure the amounts of methionine and/or SAM. Frozen samples in 1.5 ml plastic tubes were homogenized in 300 µl of cold methanol with 1× f3-mm zirconia beads using an automill (Tokken Inc) at 41.6 Hz for 2 min. The homogenates were mixed with 200 µl of methanol, 200 µl of H<sub>2</sub>O, and 200 µl of CHCl<sub>3</sub> and then vortexed for 20 min at RT. The samples were centrifuged at 20,000 g for 15 min at 4°C. The supernatant was mixed with 350 µl of H<sub>2</sub>O and vortexed for 10 min at RT. The aqueous phase was collected after centrifugation and dried in a vacuum concentrator. The samples were redissolved by 50% acetonitrile, transferred to autosampler vial, and kept at 5.0°C. The insoluble pellets were heat-denatured with 0.2 N NaOH and used to quantify total protein using a BCA protein assay kit (Thermo). Chromatographic separations in an Acquity UPLC H-Class System (Waters) were carried out under reverse-phase conditions using an Acquity UPLC HSS T3 column (2.1 × 100 mm) in infusion. A mobile phase consists of solvent A (10 mM ammonium bicarbonate, pH 7.5) and solvent B (acetonitrile). The flow rate was 0.5 ml/min at 30.0°C. Compounds were separated by gradient elution, in turn ionized and detected using a Xevo TQ-S triple quadrupole mass spectrometer coupled with an electro-spray ionization source (Waters). Precursor ion was scanned at m/z (MH+: 399.143 &gt; 250.092 for SAM, and 150.057 &gt; 104.053 for methionine) by multiple reaction monitoring and established methods using individual authentic compounds and biological samples. The peak area of a target metabolite was analyzed using MassLynx 4.1 software (Waters). Metabolite signals were then normalized to the total protein level of the corresponding sample after subtracting the values from the blank sample. A two-tailed unpaired t-test was used to test between samples.</p></sec><sec id="s4-10"><title>RT-qPCR</title><p>For RT-qPCR, the total RNA was extracted from 30 discs per sample by using the Maxwell RSC simplyRNA Tissue Kit (Promega). Total RNA (250 ng) was subjected to DNase digestion, followed by reverse transcription using the ReverTra Ace qPCR RT Kit (Toyobo). qPCR was performed using the FastStart Essential DNA Green Master Mix (Roche). Rpl32 was used as an internal control. Error bars represent the SE. Primers used for qPCR are shown in <xref ref-type="supplementary-material" rid="supp4">Supplementary file 4</xref>.</p></sec><sec id="s4-11"><title>HPG incorporation assay</title><p>Methionine incorporation was monitored by the methionine analog HPG-based on Click-iT HPG Alexa Fluor Protein Synthesis Assay kit (Invitrogen). Wing discs were dissected in S2 medium. After dissection, discs were incubated with the S2 medium containing 5 mM HPG for 30 min. After washing with PBS, the discs were fixed by 4% PFA for 30 min. The discs were then washed by PBS three times and permeabilized with PBS with 0.1% Triton X-100 for 20 min, followed by 15 min incubation with freshly prepared Click-iT reaction cocktail. The discs were then washed by PBS three times and PBS with 0.1% Triton X-100 once, and incubated with DAPI for 30 min. Fluorescent images were acquired with the confocal microscope (Zeiss LSM 880). The mean intensity of HPG in <italic>Src42A CA</italic> expressing cells were quantified by using ImageJ.</p></sec><sec id="s4-12"><title>Statistical analysis</title><p>Statistical tests used were indicated in the figure captions. All the data plotted in each graph were summarized in <xref ref-type="supplementary-material" rid="supp3">Supplementary file 3</xref>. Sample sizes were determined empirically based on the observed effects. All the statistical analyses were performed using Graphpad Prism 9. A two-tailed unpaired t-test was used to test between two samples. The number of samples is shown in <xref ref-type="supplementary-material" rid="supp3">Supplementary file 3</xref>. One-way ANOVA with Sidak’s multiple comparisons test was used to test among groups. Statistical significance is shown by asterisk; ∗p&lt;0.05, ∗∗p≦0.01, ∗∗∗p≦0.001, ∗∗∗∗p≦0.0001.</p></sec></sec></body><back><ack id="ack"><title>Acknowledgements</title><p>This work was supported by AMED-PRIME (17939907) and the JSPS KAKENHI (JP16H0622) to SKY and by National Research Foundation of Korea grant (NRF-2020R1A5A1018081) to JC.</p></ack><sec id="s5" sec-type="additional-information"><title>Additional information</title><fn-group content-type="competing-interest"><title>Competing interests</title><fn fn-type="COI-statement" id="conf1"><p>No competing interests declared</p></fn></fn-group><fn-group content-type="author-contribution"><title>Author contributions</title><fn fn-type="con" id="con1"><p>Conceptualization, Formal analysis, Investigation, Writing - review and editing</p></fn><fn fn-type="con" id="con2"><p>Investigation, Methodology</p></fn><fn fn-type="con" id="con3"><p>Investigation, Methodology</p></fn><fn fn-type="con" id="con4"><p>Formal analysis, Investigation, Methodology</p></fn><fn fn-type="con" id="con5"><p>Investigation, Methodology</p></fn><fn fn-type="con" id="con6"><p>Investigation, Methodology</p></fn><fn fn-type="con" id="con7"><p>Resources, Formal analysis</p></fn><fn fn-type="con" id="con8"><p>Resources, Methodology</p></fn><fn fn-type="con" id="con9"><p>Supervision, Project administration, Writing - review and editing</p></fn><fn fn-type="con" id="con10"><p>Conceptualization, Formal analysis, Supervision, Funding acquisition, Investigation, Writing - original draft</p></fn></fn-group></sec><sec id="s6" sec-type="supplementary-material"><title>Additional files</title><supplementary-material id="supp1"><label>Supplementary file 1.</label><caption><title>Stock information and results in the first screening.</title><p>The table shows stock IDs and results of survivor numbers and the wing phenotype.</p></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-59809-supp1-v1.xlsx"/></supplementary-material><supplementary-material id="supp2"><label>Supplementary file 2.</label><caption><title>Food composition.</title><p>The table shows components of the fly foods that were used for dietary restriction, amino acid subtraction, and methionine addition experiments.</p></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-59809-supp2-v1.xlsx"/></supplementary-material><supplementary-material id="supp3"><label>Supplementary file 3.</label><caption><title>All the statistics data.</title><p>The table shows all the plotted data and information of statistic analyses performed in this manuscript.</p></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-59809-supp3-v1.xlsx"/></supplementary-material><supplementary-material id="supp4"><label>Supplementary file 4.</label><caption><title>Primer information.</title><p>The table shows sequences of the primers used in this study.</p></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-59809-supp4-v1.xlsx"/></supplementary-material><supplementary-material id="transrepform"><label>Transparent reporting form</label><media mime-subtype="docx" mimetype="application" xlink:href="elife-59809-transrepform-v1.docx"/></supplementary-material></sec><sec id="s7" sec-type="data-availability"><title>Data availability</title><p>All data generated or analysed during this study are included in the manuscript and supporting files.</p></sec><ref-list><title>References</title><ref id="bib1"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Adachi-Yamada</surname> <given-names>T</given-names></name><name><surname>Nakamura</surname> <given-names>M</given-names></name><name><surname>Irie</surname> <given-names>K</given-names></name><name><surname>Tomoyasu</surname> <given-names>Y</given-names></name><name><surname>Sano</surname> <given-names>Y</given-names></name><name><surname>Mori</surname> <given-names>E</given-names></name><name><surname>Goto</surname> <given-names>S</given-names></name><name><surname>Ueno</surname> <given-names>N</given-names></name><name><surname>Nishida</surname> <given-names>Y</given-names></name><name><surname>Matsumoto</surname> <given-names>K</given-names></name></person-group><year iso-8601-date="1999">1999</year><article-title>p38 mitogen-activated protein kinase can be involved in transforming growth factor beta superfamily signal transduction in <italic>Drosophila</italic> wing morphogenesis</article-title><source>Molecular and Cellular Biology</source><volume>19</volume><fpage>2322</fpage><lpage>2329</lpage><pub-id pub-id-type="doi">10.1128/MCB.19.3.2322</pub-id><pub-id pub-id-type="pmid">10022918</pub-id></element-citation></ref><ref id="bib2"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Badgley</surname> <given-names>MA</given-names></name><name><surname>Kremer</surname> <given-names>DM</given-names></name><name><surname>Maurer</surname> <given-names>HC</given-names></name><name><surname>DelGiorno</surname> <given-names>KE</given-names></name><name><surname>Lee</surname> <given-names>HJ</given-names></name><name><surname>Purohit</surname> <given-names>V</given-names></name><name><surname>Sagalovskiy</surname> <given-names>IR</given-names></name><name><surname>Ma</surname> <given-names>A</given-names></name><name><surname>Kapilian</surname> <given-names>J</given-names></name><name><surname>Firl</surname> <given-names>CEM</given-names></name><name><surname>Decker</surname> <given-names>AR</given-names></name><name><surname>Sastra</surname> <given-names>SA</given-names></name><name><surname>Palermo</surname> <given-names>CF</given-names></name><name><surname>Andrade</surname> <given-names>LR</given-names></name><name><surname>Sajjakulnukit</surname> <given-names>P</given-names></name><name><surname>Zhang</surname> <given-names>L</given-names></name><name><surname>Tolstyka</surname> <given-names>ZP</given-names></name><name><surname>Hirschhorn</surname> <given-names>T</given-names></name><name><surname>Lamb</surname> <given-names>C</given-names></name><name><surname>Liu</surname> <given-names>T</given-names></name><name><surname>Gu</surname> <given-names>W</given-names></name><name><surname>Seeley</surname> <given-names>ES</given-names></name><name><surname>Stone</surname> <given-names>E</given-names></name><name><surname>Georgiou</surname> <given-names>G</given-names></name><name><surname>Manor</surname> <given-names>U</given-names></name><name><surname>Iuga</surname> <given-names>A</given-names></name><name><surname>Wahl</surname> <given-names>GM</given-names></name><name><surname>Stockwell</surname> <given-names>BR</given-names></name><name><surname>Lyssiotis</surname> <given-names>CA</given-names></name><name><surname>Olive</surname> <given-names>KP</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Cysteine depletion induces pancreatic tumor ferroptosis in mice</article-title><source>Science</source><volume>368</volume><fpage>85</fpage><lpage>89</lpage><pub-id pub-id-type="doi">10.1126/science.aaw9872</pub-id><pub-id pub-id-type="pmid">32241947</pub-id></element-citation></ref><ref id="bib3"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname> <given-names>J</given-names></name><name><surname>Xie</surname> <given-names>C</given-names></name><name><surname>Tian</surname> <given-names>L</given-names></name><name><surname>Hong</surname> <given-names>L</given-names></name><name><surname>Wu</surname> <given-names>X</given-names></name><name><surname>Han</surname> <given-names>J</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Participation of the p38 pathway in <italic>Drosophila</italic> host defense against pathogenic Bacteria and fungi</article-title><source>PNAS</source><volume>107</volume><fpage>20774</fpage><lpage>20779</lpage><pub-id pub-id-type="doi">10.1073/pnas.1009223107</pub-id><pub-id pub-id-type="pmid">21076039</pub-id></element-citation></ref><ref id="bib4"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Clark</surname> <given-names>RI</given-names></name><name><surname>Tan</surname> <given-names>SW</given-names></name><name><surname>Péan</surname> <given-names>CB</given-names></name><name><surname>Roostalu</surname> <given-names>U</given-names></name><name><surname>Vivancos</surname> <given-names>V</given-names></name><name><surname>Bronda</surname> <given-names>K</given-names></name><name><surname>Pilátová</surname> <given-names>M</given-names></name><name><surname>Fu</surname> <given-names>J</given-names></name><name><surname>Walker</surname> <given-names>DW</given-names></name><name><surname>Berdeaux</surname> <given-names>R</given-names></name><name><surname>Geissmann</surname> <given-names>F</given-names></name><name><surname>Dionne</surname> <given-names>MS</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>MEF2 is an in vivo immune-metabolic switch</article-title><source>Cell</source><volume>155</volume><fpage>435</fpage><lpage>447</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2013.09.007</pub-id><pub-id pub-id-type="pmid">24075010</pub-id></element-citation></ref><ref id="bib5"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cordero</surname> <given-names>JB</given-names></name><name><surname>Ridgway</surname> <given-names>RA</given-names></name><name><surname>Valeri</surname> <given-names>N</given-names></name><name><surname>Nixon</surname> <given-names>C</given-names></name><name><surname>Frame</surname> <given-names>MC</given-names></name><name><surname>Muller</surname> <given-names>WJ</given-names></name><name><surname>Vidal</surname> <given-names>M</given-names></name><name><surname>Sansom</surname> <given-names>OJ</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>c-Src drives intestinal regeneration and transformation</article-title><source>The EMBO Journal</source><volume>33</volume><fpage>1474</fpage><lpage>1491</lpage><pub-id pub-id-type="doi">10.1002/embj.201387454</pub-id><pub-id pub-id-type="pmid">24788409</pub-id></element-citation></ref><ref id="bib6"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cully</surname> <given-names>M</given-names></name><name><surname>Genevet</surname> <given-names>A</given-names></name><name><surname>Warne</surname> <given-names>P</given-names></name><name><surname>Treins</surname> <given-names>C</given-names></name><name><surname>Liu</surname> <given-names>T</given-names></name><name><surname>Bastien</surname> <given-names>J</given-names></name><name><surname>Baum</surname> <given-names>B</given-names></name><name><surname>Tapon</surname> <given-names>N</given-names></name><name><surname>Leevers</surname> <given-names>SJ</given-names></name><name><surname>Downward</surname> <given-names>J</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>A role for p38 stress-activated protein kinase in regulation of cell growth via TORC1</article-title><source>Molecular and Cellular Biology</source><volume>30</volume><fpage>481</fpage><lpage>495</lpage><pub-id pub-id-type="doi">10.1128/MCB.00688-09</pub-id><pub-id pub-id-type="pmid">19917724</pub-id></element-citation></ref><ref id="bib7"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>DeBerardinis</surname> <given-names>RJ</given-names></name><name><surname>Chandel</surname> <given-names>NS</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Fundamentals of cancer metabolism</article-title><source>Science Advances</source><volume>2</volume><elocation-id>e1600200</elocation-id><pub-id pub-id-type="doi">10.1126/sciadv.1600200</pub-id><pub-id pub-id-type="pmid">27386546</pub-id></element-citation></ref><ref id="bib8"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Enomoto</surname> <given-names>M</given-names></name><name><surname>Igaki</surname> <given-names>T</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Src controls tumorigenesis via JNK-dependent regulation of the hippo pathway in <italic>Drosophila</italic></article-title><source>EMBO Reports</source><volume>14</volume><fpage>65</fpage><lpage>72</lpage><pub-id pub-id-type="doi">10.1038/embor.2012.185</pub-id><pub-id pub-id-type="pmid">23196366</pub-id></element-citation></ref><ref id="bib9"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Evan</surname> <given-names>GI</given-names></name><name><surname>Wyllie</surname> <given-names>AH</given-names></name><name><surname>Gilbert</surname> <given-names>CS</given-names></name><name><surname>Littlewood</surname> <given-names>TD</given-names></name><name><surname>Land</surname> <given-names>H</given-names></name><name><surname>Brooks</surname> <given-names>M</given-names></name><name><surname>Waters</surname> <given-names>CM</given-names></name><name><surname>Penn</surname> <given-names>LZ</given-names></name><name><surname>Hancock</surname> <given-names>DC</given-names></name></person-group><year iso-8601-date="1992">1992</year><article-title>Induction of apoptosis in fibroblasts by c-myc protein</article-title><source>Cell</source><volume>69</volume><fpage>119</fpage><lpage>128</lpage><pub-id pub-id-type="doi">10.1016/0092-8674(92)90123-T</pub-id><pub-id pub-id-type="pmid">1555236</pub-id></element-citation></ref><ref id="bib10"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Evan</surname> <given-names>G</given-names></name><name><surname>Harrington</surname> <given-names>E</given-names></name><name><surname>Fanidi</surname> <given-names>A</given-names></name><name><surname>Land</surname> <given-names>H</given-names></name><name><surname>Amati</surname> <given-names>B</given-names></name><name><surname>Bennett</surname> <given-names>M</given-names></name></person-group><year iso-8601-date="1994">1994</year><article-title>Integrated control of cell proliferation and cell death by the c-myc oncogene</article-title><source>Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences</source><volume>345</volume><fpage>269</fpage><lpage>275</lpage><pub-id pub-id-type="doi">10.1098/rstb.1994.0105</pub-id><pub-id pub-id-type="pmid">7846125</pub-id></element-citation></ref><ref id="bib11"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fernández</surname> <given-names>BG</given-names></name><name><surname>Jezowska</surname> <given-names>B</given-names></name><name><surname>Janody</surname> <given-names>F</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title><italic>Drosophila</italic> actin-Capping protein limits JNK activation by the src proto-oncogene</article-title><source>Oncogene</source><volume>33</volume><fpage>2027</fpage><lpage>2039</lpage><pub-id pub-id-type="doi">10.1038/onc.2013.155</pub-id><pub-id pub-id-type="pmid">23644660</pub-id></element-citation></ref><ref id="bib12"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gao</surname> <given-names>X</given-names></name><name><surname>Sanderson</surname> <given-names>SM</given-names></name><name><surname>Dai</surname> <given-names>Z</given-names></name><name><surname>Reid</surname> <given-names>MA</given-names></name><name><surname>Cooper</surname> <given-names>DE</given-names></name><name><surname>Lu</surname> <given-names>M</given-names></name><name><surname>Richie</surname> <given-names>JP</given-names></name><name><surname>Ciccarella</surname> <given-names>A</given-names></name><name><surname>Calcagnotto</surname> <given-names>A</given-names></name><name><surname>Mikhael</surname> <given-names>PG</given-names></name><name><surname>Mentch</surname> <given-names>SJ</given-names></name><name><surname>Liu</surname> <given-names>J</given-names></name><name><surname>Ables</surname> <given-names>G</given-names></name><name><surname>Kirsch</surname> <given-names>DG</given-names></name><name><surname>Hsu</surname> <given-names>DS</given-names></name><name><surname>Nichenametla</surname> <given-names>SN</given-names></name><name><surname>Locasale</surname> <given-names>JW</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Dietary methionine influences therapy in mouse Cancer models and alters human metabolism</article-title><source>Nature</source><volume>572</volume><fpage>397</fpage><lpage>401</lpage><pub-id pub-id-type="doi">10.1038/s41586-019-1437-3</pub-id><pub-id pub-id-type="pmid">31367041</pub-id></element-citation></ref><ref id="bib13"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gargalionis</surname> <given-names>AN</given-names></name><name><surname>Karamouzis</surname> <given-names>MV</given-names></name><name><surname>Papavassiliou</surname> <given-names>AG</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>The molecular rationale of src inhibition in colorectal carcinomas</article-title><source>International Journal of Cancer</source><volume>134</volume><fpage>2019</fpage><lpage>2029</lpage><pub-id pub-id-type="doi">10.1002/ijc.28299</pub-id><pub-id pub-id-type="pmid">23733480</pub-id></element-citation></ref><ref id="bib14"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Goberdhan</surname> <given-names>DC</given-names></name><name><surname>Meredith</surname> <given-names>D</given-names></name><name><surname>Boyd</surname> <given-names>CA</given-names></name><name><surname>Wilson</surname> <given-names>C</given-names></name></person-group><year iso-8601-date="2005">2005</year><article-title>PAT-related amino acid transporters regulate growth via a novel mechanism that does not require bulk transport of amino acids</article-title><source>Development</source><volume>132</volume><fpage>2365</fpage><lpage>2375</lpage><pub-id pub-id-type="doi">10.1242/dev.01821</pub-id><pub-id pub-id-type="pmid">15843412</pub-id></element-citation></ref><ref id="bib15"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Goncalves</surname> <given-names>MD</given-names></name><name><surname>Lu</surname> <given-names>C</given-names></name><name><surname>Tutnauer</surname> <given-names>J</given-names></name><name><surname>Hartman</surname> <given-names>TE</given-names></name><name><surname>Hwang</surname> <given-names>SK</given-names></name><name><surname>Murphy</surname> <given-names>CJ</given-names></name><name><surname>Pauli</surname> <given-names>C</given-names></name><name><surname>Morris</surname> <given-names>R</given-names></name><name><surname>Taylor</surname> <given-names>S</given-names></name><name><surname>Bosch</surname> <given-names>K</given-names></name><name><surname>Yang</surname> <given-names>S</given-names></name><name><surname>Wang</surname> <given-names>Y</given-names></name><name><surname>Van Riper</surname> <given-names>J</given-names></name><name><surname>Lekaye</surname> <given-names>HC</given-names></name><name><surname>Roper</surname> <given-names>J</given-names></name><name><surname>Kim</surname> <given-names>Y</given-names></name><name><surname>Chen</surname> <given-names>Q</given-names></name><name><surname>Gross</surname> <given-names>SS</given-names></name><name><surname>Rhee</surname> <given-names>KY</given-names></name><name><surname>Cantley</surname> <given-names>LC</given-names></name><name><surname>Yun</surname> <given-names>J</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>High-fructose corn syrup enhances intestinal tumor growth in mice</article-title><source>Science</source><volume>363</volume><fpage>1345</fpage><lpage>1349</lpage><pub-id pub-id-type="doi">10.1126/science.aat8515</pub-id><pub-id pub-id-type="pmid">30898933</pub-id></element-citation></ref><ref id="bib16"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gonzalez</surname> <given-names>PS</given-names></name><name><surname>O'Prey</surname> <given-names>J</given-names></name><name><surname>Cardaci</surname> <given-names>S</given-names></name><name><surname>Barthet</surname> <given-names>VJA</given-names></name><name><surname>Sakamaki</surname> <given-names>JI</given-names></name><name><surname>Beaumatin</surname> <given-names>F</given-names></name><name><surname>Roseweir</surname> <given-names>A</given-names></name><name><surname>Gay</surname> <given-names>DM</given-names></name><name><surname>Mackay</surname> <given-names>G</given-names></name><name><surname>Malviya</surname> <given-names>G</given-names></name><name><surname>Kania</surname> <given-names>E</given-names></name><name><surname>Ritchie</surname> <given-names>S</given-names></name><name><surname>Baudot</surname> <given-names>AD</given-names></name><name><surname>Zunino</surname> <given-names>B</given-names></name><name><surname>Mrowinska</surname> <given-names>A</given-names></name><name><surname>Nixon</surname> <given-names>C</given-names></name><name><surname>Ennis</surname> <given-names>D</given-names></name><name><surname>Hoyle</surname> <given-names>A</given-names></name><name><surname>Millan</surname> <given-names>D</given-names></name><name><surname>McNeish</surname> <given-names>IA</given-names></name><name><surname>Sansom</surname> <given-names>OJ</given-names></name><name><surname>Edwards</surname> <given-names>J</given-names></name><name><surname>Ryan</surname> <given-names>KM</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Mannose impairs tumour growth and enhances chemotherapy</article-title><source>Nature</source><volume>563</volume><fpage>719</fpage><lpage>723</lpage><pub-id pub-id-type="doi">10.1038/s41586-018-0729-3</pub-id><pub-id pub-id-type="pmid">30464341</pub-id></element-citation></ref><ref id="bib17"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gu</surname> <given-names>X</given-names></name><name><surname>Orozco</surname> <given-names>JM</given-names></name><name><surname>Saxton</surname> <given-names>RA</given-names></name><name><surname>Condon</surname> <given-names>KJ</given-names></name><name><surname>Liu</surname> <given-names>GY</given-names></name><name><surname>Krawczyk</surname> <given-names>PA</given-names></name><name><surname>Scaria</surname> <given-names>SM</given-names></name><name><surname>Harper</surname> <given-names>JW</given-names></name><name><surname>Gygi</surname> <given-names>SP</given-names></name><name><surname>Sabatini</surname> <given-names>DM</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>SAMTOR i<italic>s</italic> an <italic>S</italic>-adenosylmethionine sensor for the mTORC1 pathway</article-title><source>Science</source><volume>358</volume><fpage>813</fpage><lpage>818</lpage><pub-id pub-id-type="doi">10.1126/science.aao3265</pub-id><pub-id pub-id-type="pmid">29123071</pub-id></element-citation></ref><ref id="bib18"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hanahan</surname> <given-names>D</given-names></name><name><surname>Weinberg</surname> <given-names>RA</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Hallmarks of Cancer: the next generation</article-title><source>Cell</source><volume>144</volume><fpage>646</fpage><lpage>674</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2011.02.013</pub-id><pub-id pub-id-type="pmid">21376230</pub-id></element-citation></ref><ref id="bib19"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ho</surname> <given-names>DM</given-names></name><name><surname>Pallavi</surname> <given-names>SK</given-names></name><name><surname>Artavanis-Tsakonas</surname> <given-names>S</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>The Notch-mediated hyperplasia circuitry in <italic>Drosophila</italic> reveals a Src-JNK signaling Axis</article-title><source>eLife</source><volume>4</volume><elocation-id>e05996</elocation-id><pub-id pub-id-type="doi">10.7554/eLife.05996</pub-id><pub-id pub-id-type="pmid">26222204</pub-id></element-citation></ref><ref id="bib20"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hoffman</surname> <given-names>B</given-names></name><name><surname>Liebermann</surname> <given-names>DA</given-names></name></person-group><year iso-8601-date="1998">1998</year><article-title>The proto-oncogene c-myc and apoptosis</article-title><source>Oncogene</source><volume>17</volume><fpage>3351</fpage><lpage>3357</lpage><pub-id pub-id-type="doi">10.1038/sj.onc.1202592</pub-id><pub-id pub-id-type="pmid">9916997</pub-id></element-citation></ref><ref id="bib21"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ishizawar</surname> <given-names>R</given-names></name><name><surname>Parsons</surname> <given-names>SJ</given-names></name></person-group><year iso-8601-date="2004">2004</year><article-title>c-Src and cooperating partners in human Cancer</article-title><source>Cancer Cell</source><volume>6</volume><fpage>209</fpage><lpage>214</lpage><pub-id pub-id-type="doi">10.1016/j.ccr.2004.09.001</pub-id><pub-id pub-id-type="pmid">15380511</pub-id></element-citation></ref><ref id="bib22"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kanarek</surname> <given-names>N</given-names></name><name><surname>Keys</surname> <given-names>HR</given-names></name><name><surname>Cantor</surname> <given-names>JR</given-names></name><name><surname>Lewis</surname> <given-names>CA</given-names></name><name><surname>Chan</surname> <given-names>SH</given-names></name><name><surname>Kunchok</surname> <given-names>T</given-names></name><name><surname>Abu-Remaileh</surname> <given-names>M</given-names></name><name><surname>Freinkman</surname> <given-names>E</given-names></name><name><surname>Schweitzer</surname> <given-names>LD</given-names></name><name><surname>Sabatini</surname> <given-names>DM</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Histidine catabolism is a major determinant of methotrexate sensitivity</article-title><source>Nature</source><volume>559</volume><fpage>632</fpage><lpage>636</lpage><pub-id pub-id-type="doi">10.1038/s41586-018-0316-7</pub-id><pub-id pub-id-type="pmid">29995852</pub-id></element-citation></ref><ref id="bib23"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Karim</surname> <given-names>FD</given-names></name><name><surname>Rubin</surname> <given-names>GM</given-names></name></person-group><year iso-8601-date="1998">1998</year><article-title>Ectopic expression of activated Ras1 induces hyperplastic growth and increased cell death in <italic>Drosophila</italic> imaginal tissues</article-title><source>Development</source><volume>125</volume><fpage>1</fpage><lpage>9</lpage><pub-id pub-id-type="pmid">9389658</pub-id></element-citation></ref><ref id="bib24"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kashio</surname> <given-names>S</given-names></name><name><surname>Obata</surname> <given-names>F</given-names></name><name><surname>Zhang</surname> <given-names>L</given-names></name><name><surname>Katsuyama</surname> <given-names>T</given-names></name><name><surname>Chihara</surname> <given-names>T</given-names></name><name><surname>Miura</surname> <given-names>M</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Tissue nonautonomous effects of fat body methionine metabolism on imaginal disc repair in <italic>Drosophila</italic></article-title><source>PNAS</source><volume>113</volume><fpage>1835</fpage><lpage>1840</lpage><pub-id pub-id-type="doi">10.1073/pnas.1523681113</pub-id><pub-id pub-id-type="pmid">26831070</pub-id></element-citation></ref><ref id="bib25"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname> <given-names>W</given-names></name><name><surname>Jang</surname> <given-names>YG</given-names></name><name><surname>Yang</surname> <given-names>J</given-names></name><name><surname>Chung</surname> <given-names>J</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Spatial activation of TORC1 is regulated by hedgehog and E2F1 signaling in the <italic>Drosophila</italic> Eye</article-title><source>Developmental Cell</source><volume>42</volume><fpage>363</fpage><lpage>375</lpage><pub-id pub-id-type="doi">10.1016/j.devcel.2017.07.020</pub-id><pub-id pub-id-type="pmid">28829944</pub-id></element-citation></ref><ref id="bib26"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname> <given-names>J</given-names></name><name><surname>Guan</surname> <given-names>KL</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>mTOR as a central hub of nutrient signalling and cell growth</article-title><source>Nature Cell Biology</source><volume>21</volume><fpage>63</fpage><lpage>71</lpage><pub-id pub-id-type="doi">10.1038/s41556-018-0205-1</pub-id><pub-id pub-id-type="pmid">30602761</pub-id></element-citation></ref><ref id="bib27"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Knott</surname> <given-names>SRV</given-names></name><name><surname>Wagenblast</surname> <given-names>E</given-names></name><name><surname>Khan</surname> <given-names>S</given-names></name><name><surname>Kim</surname> <given-names>SY</given-names></name><name><surname>Soto</surname> <given-names>M</given-names></name><name><surname>Wagner</surname> <given-names>M</given-names></name><name><surname>Turgeon</surname> <given-names>MO</given-names></name><name><surname>Fish</surname> <given-names>L</given-names></name><name><surname>Erard</surname> <given-names>N</given-names></name><name><surname>Gable</surname> <given-names>AL</given-names></name><name><surname>Maceli</surname> <given-names>AR</given-names></name><name><surname>Dickopf</surname> <given-names>S</given-names></name><name><surname>Papachristou</surname> <given-names>EK</given-names></name><name><surname>D'Santos</surname> <given-names>CS</given-names></name><name><surname>Carey</surname> <given-names>LA</given-names></name><name><surname>Wilkinson</surname> <given-names>JE</given-names></name><name><surname>Harrell</surname> <given-names>JC</given-names></name><name><surname>Perou</surname> <given-names>CM</given-names></name><name><surname>Goodarzi</surname> <given-names>H</given-names></name><name><surname>Poulogiannis</surname> <given-names>G</given-names></name><name><surname>Hannon</surname> <given-names>GJ</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Asparagine bioavailability governs metastasis in a model of breast Cancer</article-title><source>Nature</source><volume>554</volume><fpage>378</fpage><lpage>381</lpage><pub-id pub-id-type="doi">10.1038/nature25465</pub-id><pub-id pub-id-type="pmid">29414946</pub-id></element-citation></ref><ref id="bib28"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kussick</surname> <given-names>SJ</given-names></name><name><surname>Basler</surname> <given-names>K</given-names></name><name><surname>Cooper</surname> <given-names>JA</given-names></name></person-group><year iso-8601-date="1993">1993</year><article-title>Ras1-dependent signaling by ectopically-expressed <italic>Drosophila</italic> src gene product in the embryo and developing eye</article-title><source>Oncogene</source><volume>8</volume><fpage>2791</fpage><lpage>2803</lpage><pub-id pub-id-type="pmid">8378088</pub-id></element-citation></ref><ref id="bib29"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lai</surname> <given-names>HS</given-names></name><name><surname>Lee</surname> <given-names>JC</given-names></name><name><surname>Lee</surname> <given-names>PH</given-names></name><name><surname>Wang</surname> <given-names>ST</given-names></name><name><surname>Chen</surname> <given-names>WJ</given-names></name></person-group><year iso-8601-date="2005">2005</year><article-title>Plasma free amino acid profile in Cancer patients</article-title><source>Seminars in Cancer Biology</source><volume>15</volume><fpage>267</fpage><lpage>276</lpage><pub-id pub-id-type="doi">10.1016/j.semcancer.2005.04.003</pub-id><pub-id pub-id-type="pmid">15894488</pub-id></element-citation></ref><ref id="bib30"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname> <given-names>BC</given-names></name><name><surname>Kaya</surname> <given-names>A</given-names></name><name><surname>Ma</surname> <given-names>S</given-names></name><name><surname>Kim</surname> <given-names>G</given-names></name><name><surname>Gerashchenko</surname> <given-names>MV</given-names></name><name><surname>Yim</surname> <given-names>SH</given-names></name><name><surname>Hu</surname> <given-names>Z</given-names></name><name><surname>Harshman</surname> <given-names>LG</given-names></name><name><surname>Gladyshev</surname> <given-names>VN</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Methionine restriction extends lifespan of <italic>Drosophila melanogaster</italic> under conditions of low amino-acid status</article-title><source>Nature Communications</source><volume>5</volume><elocation-id>3592</elocation-id><pub-id pub-id-type="doi">10.1038/ncomms4592</pub-id><pub-id pub-id-type="pmid">24710037</pub-id></element-citation></ref><ref id="bib31"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lowe</surname> <given-names>SW</given-names></name><name><surname>Cepero</surname> <given-names>E</given-names></name><name><surname>Evan</surname> <given-names>G</given-names></name></person-group><year iso-8601-date="2004">2004</year><article-title>Intrinsic tumour suppression</article-title><source>Nature</source><volume>432</volume><fpage>307</fpage><lpage>315</lpage><pub-id pub-id-type="doi">10.1038/nature03098</pub-id><pub-id pub-id-type="pmid">15549092</pub-id></element-citation></ref><ref id="bib32"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ma</surname> <given-names>X</given-names></name><name><surname>Shao</surname> <given-names>Y</given-names></name><name><surname>Zheng</surname> <given-names>H</given-names></name><name><surname>Li</surname> <given-names>M</given-names></name><name><surname>Li</surname> <given-names>W</given-names></name><name><surname>Xue</surname> <given-names>L</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Src42A modulates tumor invasion and cell death via ben/dUev1a-mediated JNK activation in <italic>Drosophila</italic></article-title><source>Cell Death &amp; Disease</source><volume>4</volume><elocation-id>e864</elocation-id><pub-id pub-id-type="doi">10.1038/cddis.2013.392</pub-id><pub-id pub-id-type="pmid">24136228</pub-id></element-citation></ref><ref id="bib33"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Maddocks</surname> <given-names>OD</given-names></name><name><surname>Berkers</surname> <given-names>CR</given-names></name><name><surname>Mason</surname> <given-names>SM</given-names></name><name><surname>Zheng</surname> <given-names>L</given-names></name><name><surname>Blyth</surname> <given-names>K</given-names></name><name><surname>Gottlieb</surname> <given-names>E</given-names></name><name><surname>Vousden</surname> <given-names>KH</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Serine starvation induces stress and p53-dependent metabolic remodelling in Cancer cells</article-title><source>Nature</source><volume>493</volume><fpage>542</fpage><lpage>546</lpage><pub-id pub-id-type="doi">10.1038/nature11743</pub-id><pub-id pub-id-type="pmid">23242140</pub-id></element-citation></ref><ref id="bib34"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Maddocks</surname> <given-names>ODK</given-names></name><name><surname>Athineos</surname> <given-names>D</given-names></name><name><surname>Cheung</surname> <given-names>EC</given-names></name><name><surname>Lee</surname> <given-names>P</given-names></name><name><surname>Zhang</surname> <given-names>T</given-names></name><name><surname>van den Broek</surname> <given-names>NJF</given-names></name><name><surname>Mackay</surname> <given-names>GM</given-names></name><name><surname>Labuschagne</surname> <given-names>CF</given-names></name><name><surname>Gay</surname> <given-names>D</given-names></name><name><surname>Kruiswijk</surname> <given-names>F</given-names></name><name><surname>Blagih</surname> <given-names>J</given-names></name><name><surname>Vincent</surname> <given-names>DF</given-names></name><name><surname>Campbell</surname> <given-names>KJ</given-names></name><name><surname>Ceteci</surname> <given-names>F</given-names></name><name><surname>Sansom</surname> <given-names>OJ</given-names></name><name><surname>Blyth</surname> <given-names>K</given-names></name><name><surname>Vousden</surname> <given-names>KH</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Modulating the therapeutic response of tumours to dietary serine and glycine starvation</article-title><source>Nature</source><volume>544</volume><fpage>372</fpage><lpage>376</lpage><pub-id pub-id-type="doi">10.1038/nature22056</pub-id><pub-id pub-id-type="pmid">28425994</pub-id></element-citation></ref><ref id="bib35"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Malloy</surname> <given-names>VL</given-names></name><name><surname>Perrone</surname> <given-names>CE</given-names></name><name><surname>Mattocks</surname> <given-names>DA</given-names></name><name><surname>Ables</surname> <given-names>GP</given-names></name><name><surname>Caliendo</surname> <given-names>NS</given-names></name><name><surname>Orentreich</surname> <given-names>DS</given-names></name><name><surname>Orentreich</surname> <given-names>N</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Methionine restriction prevents the progression of hepatic steatosis in leptin-deficient obese mice</article-title><source>Metabolism</source><volume>62</volume><fpage>1651</fpage><lpage>1661</lpage><pub-id pub-id-type="doi">10.1016/j.metabol.2013.06.012</pub-id><pub-id pub-id-type="pmid">23928105</pub-id></element-citation></ref><ref id="bib36"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Newton</surname> <given-names>H</given-names></name><name><surname>Wang</surname> <given-names>YF</given-names></name><name><surname>Camplese</surname> <given-names>L</given-names></name><name><surname>Mokochinski</surname> <given-names>JB</given-names></name><name><surname>Kramer</surname> <given-names>HB</given-names></name><name><surname>Brown</surname> <given-names>AEX</given-names></name><name><surname>Fets</surname> <given-names>L</given-names></name><name><surname>Hirabayashi</surname> <given-names>S</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Systemic muscle wasting and coordinated tumour response drive tumourigenesis</article-title><source>Nature Communications</source><volume>11</volume><elocation-id>4653</elocation-id><pub-id pub-id-type="doi">10.1038/s41467-020-18502-9</pub-id><pub-id pub-id-type="pmid">32938923</pub-id></element-citation></ref><ref id="bib37"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nihalani</surname> <given-names>D</given-names></name><name><surname>Meyer</surname> <given-names>D</given-names></name><name><surname>Pajni</surname> <given-names>S</given-names></name><name><surname>Holzman</surname> <given-names>LB</given-names></name></person-group><year iso-8601-date="2001">2001</year><article-title>Mixed lineage kinase-dependent JNK activation is governed by interactions of scaffold protein JIP with MAPK module components</article-title><source>The EMBO Journal</source><volume>20</volume><fpage>3447</fpage><lpage>3458</lpage><pub-id pub-id-type="doi">10.1093/emboj/20.13.3447</pub-id></element-citation></ref><ref id="bib38"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Obata</surname> <given-names>F</given-names></name><name><surname>Miura</surname> <given-names>M</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Enhancing S-adenosyl-methionine catabolism extends <italic>Drosophila</italic> lifespan</article-title><source>Nature Communications</source><volume>6</volume><elocation-id>8332</elocation-id><pub-id pub-id-type="doi">10.1038/ncomms9332</pub-id><pub-id pub-id-type="pmid">26383889</pub-id></element-citation></ref><ref id="bib39"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Orentreich</surname> <given-names>N</given-names></name><name><surname>Matias</surname> <given-names>JR</given-names></name><name><surname>DeFelice</surname> <given-names>A</given-names></name><name><surname>Zimmerman</surname> <given-names>JA</given-names></name></person-group><year iso-8601-date="1993">1993</year><article-title>Low methionine ingestion by rats extends life span</article-title><source>The Journal of Nutrition</source><volume>123</volume><fpage>269</fpage><lpage>274</lpage><pub-id pub-id-type="doi">10.1093/jn/123.2.269</pub-id><pub-id pub-id-type="pmid">8429371</pub-id></element-citation></ref><ref id="bib40"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pavlova</surname> <given-names>NN</given-names></name><name><surname>Thompson</surname> <given-names>CB</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>The emerging hallmarks of Cancer metabolism</article-title><source>Cell Metabolism</source><volume>23</volume><fpage>27</fpage><lpage>47</lpage><pub-id pub-id-type="doi">10.1016/j.cmet.2015.12.006</pub-id><pub-id pub-id-type="pmid">26771115</pub-id></element-citation></ref><ref id="bib41"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pedraza</surname> <given-names>LG</given-names></name><name><surname>Stewart</surname> <given-names>RA</given-names></name><name><surname>Li</surname> <given-names>DM</given-names></name><name><surname>Xu</surname> <given-names>T</given-names></name></person-group><year iso-8601-date="2004">2004</year><article-title><italic>Drosophila</italic> Src-family kinases function with csk to regulate cell proliferation and apoptosis</article-title><source>Oncogene</source><volume>23</volume><fpage>4754</fpage><lpage>4762</lpage><pub-id pub-id-type="doi">10.1038/sj.onc.1207635</pub-id><pub-id pub-id-type="pmid">15107833</pub-id></element-citation></ref><ref id="bib42"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Piper</surname> <given-names>MD</given-names></name><name><surname>Blanc</surname> <given-names>E</given-names></name><name><surname>Leitão-Gonçalves</surname> <given-names>R</given-names></name><name><surname>Yang</surname> <given-names>M</given-names></name><name><surname>He</surname> <given-names>X</given-names></name><name><surname>Linford</surname> <given-names>NJ</given-names></name><name><surname>Hoddinott</surname> <given-names>MP</given-names></name><name><surname>Hopfen</surname> <given-names>C</given-names></name><name><surname>Soultoukis</surname> <given-names>GA</given-names></name><name><surname>Niemeyer</surname> <given-names>C</given-names></name><name><surname>Kerr</surname> <given-names>F</given-names></name><name><surname>Pletcher</surname> <given-names>SD</given-names></name><name><surname>Ribeiro</surname> <given-names>C</given-names></name><name><surname>Partridge</surname> <given-names>L</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>A holidic medium for <italic>Drosophila melanogaster</italic></article-title><source>Nature Methods</source><volume>11</volume><fpage>100</fpage><lpage>105</lpage><pub-id pub-id-type="doi">10.1038/nmeth.2731</pub-id><pub-id pub-id-type="pmid">24240321</pub-id></element-citation></ref><ref id="bib43"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Prendergast</surname> <given-names>GC</given-names></name></person-group><year iso-8601-date="1999">1999</year><article-title>Mechanisms of apoptosis by c-Myc</article-title><source>Oncogene</source><volume>18</volume><fpage>2967</fpage><lpage>2987</lpage><pub-id pub-id-type="doi">10.1038/sj.onc.1202727</pub-id><pub-id pub-id-type="pmid">10378693</pub-id></element-citation></ref><ref id="bib44"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Read</surname> <given-names>RD</given-names></name><name><surname>Bach</surname> <given-names>EA</given-names></name><name><surname>Cagan</surname> <given-names>RL</given-names></name></person-group><year iso-8601-date="2004">2004</year><article-title><italic>Drosophila</italic> C-terminal src kinase negatively regulates organ growth and cell proliferation through inhibition of the src, jun N-terminal kinase, and STAT pathways</article-title><source>Molecular and Cellular Biology</source><volume>24</volume><fpage>6676</fpage><lpage>6689</lpage><pub-id pub-id-type="doi">10.1128/MCB.24.15.6676-6689.2004</pub-id><pub-id pub-id-type="pmid">15254235</pub-id></element-citation></ref><ref id="bib45"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ríos-Barrera</surname> <given-names>LD</given-names></name><name><surname>Riesgo-Escovar</surname> <given-names>JR</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Regulating cell morphogenesis: the <italic>Drosophila</italic> jun N-terminal kinase pathway</article-title><source>Genesis</source><volume>51</volume><fpage>147</fpage><lpage>162</lpage><pub-id pub-id-type="doi">10.1002/dvg.22354</pub-id><pub-id pub-id-type="pmid">23109363</pub-id></element-citation></ref><ref id="bib46"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rudrapatna</surname> <given-names>VA</given-names></name><name><surname>Bangi</surname> <given-names>E</given-names></name><name><surname>Cagan</surname> <given-names>RL</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>A Jnk-Rho-Actin remodeling positive feedback network directs Src-driven invasion</article-title><source>Oncogene</source><volume>33</volume><fpage>2801</fpage><lpage>2806</lpage><pub-id pub-id-type="doi">10.1038/onc.2013.232</pub-id><pub-id pub-id-type="pmid">23831567</pub-id></element-citation></ref><ref id="bib47"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ryabinina</surname> <given-names>O</given-names></name><name><surname>Subbian</surname> <given-names>E</given-names></name><name><surname>Iordanov</surname> <given-names>M</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>D-MEKK1, the <italic>Drosophila</italic> orthologue of mammalian MEKK4/MTK1, and Hemipterous/D-MKK7 mediate the activation of D-JNK by cadmium and arsenite in Schneider cells</article-title><source>BMC Cell Biology</source><volume>7</volume><fpage>7</fpage><lpage>10</lpage><pub-id pub-id-type="doi">10.1186/1471-2121-7-7</pub-id></element-citation></ref><ref id="bib48"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sabatini</surname> <given-names>DM</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Twenty-five years of mTOR: uncovering the link from nutrients to growth</article-title><source>PNAS</source><volume>114</volume><fpage>11818</fpage><lpage>11825</lpage><pub-id pub-id-type="doi">10.1073/pnas.1716173114</pub-id><pub-id pub-id-type="pmid">29078414</pub-id></element-citation></ref><ref id="bib49"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sanderson</surname> <given-names>SM</given-names></name><name><surname>Gao</surname> <given-names>X</given-names></name><name><surname>Dai</surname> <given-names>Z</given-names></name><name><surname>Locasale</surname> <given-names>JW</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Methionine metabolism in health and Cancer: a nexus of diet and precision medicine</article-title><source>Nature Reviews Cancer</source><volume>19</volume><fpage>625</fpage><lpage>637</lpage><pub-id pub-id-type="doi">10.1038/s41568-019-0187-8</pub-id><pub-id pub-id-type="pmid">31515518</pub-id></element-citation></ref><ref id="bib50"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sandu</surname> <given-names>C</given-names></name><name><surname>Ryoo</surname> <given-names>HD</given-names></name><name><surname>Steller</surname> <given-names>H</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title><italic>Drosophila</italic> IAP antagonists form multimeric complexes to promote cell death</article-title><source>Journal of Cell Biology</source><volume>190</volume><fpage>1039</fpage><lpage>1052</lpage><pub-id pub-id-type="doi">10.1083/jcb.201004086</pub-id></element-citation></ref><ref id="bib51"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sano</surname> <given-names>Y</given-names></name><name><surname>Akimaru</surname> <given-names>H</given-names></name><name><surname>Okamura</surname> <given-names>T</given-names></name><name><surname>Nagao</surname> <given-names>T</given-names></name><name><surname>Okada</surname> <given-names>M</given-names></name><name><surname>Ishii</surname> <given-names>S</given-names></name></person-group><year iso-8601-date="2005">2005</year><article-title><italic>Drosophila</italic> activating transcription factor-<sub>2</sub>is involved in stress response via activation by p38, but not c-Jun NH(2)-terminal kinase</article-title><source>Molecular Biology of the Cell</source><volume>16</volume><fpage>2934</fpage><lpage>2946</lpage><pub-id pub-id-type="doi">10.1091/mbc.e04-11-1008</pub-id><pub-id pub-id-type="pmid">15788564</pub-id></element-citation></ref><ref id="bib52"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sathyanarayana</surname> <given-names>P</given-names></name><name><surname>Barthwal</surname> <given-names>MK</given-names></name><name><surname>Lane</surname> <given-names>ME</given-names></name><name><surname>Acevedo</surname> <given-names>SF</given-names></name><name><surname>Skoulakis</surname> <given-names>EMC</given-names></name><name><surname>Bergmann</surname> <given-names>A</given-names></name><name><surname>Rana</surname> <given-names>A</given-names></name></person-group><year iso-8601-date="2003">2003</year><article-title><italic>Drosophila</italic> mixed lineage kinase/slipper, a missing biochemical link in <italic>Drosophila</italic> JNK signaling</article-title><source>Biochimica Et Biophysica Acta (BBA) - Molecular Cell Research</source><volume>1640</volume><fpage>77</fpage><lpage>84</lpage><pub-id pub-id-type="doi">10.1016/S0167-4889(03)00022-3</pub-id></element-citation></ref><ref id="bib53"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shortt</surname> <given-names>J</given-names></name><name><surname>Johnstone</surname> <given-names>RW</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Oncogenes in cell survival and cell death</article-title><source>Cold Spring Harbor Perspectives in Biology</source><volume>4</volume><elocation-id>a009829</elocation-id><pub-id pub-id-type="doi">10.1101/cshperspect.a009829</pub-id><pub-id pub-id-type="pmid">23209150</pub-id></element-citation></ref><ref id="bib54"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Siegrist</surname> <given-names>SE</given-names></name><name><surname>Haque</surname> <given-names>NS</given-names></name><name><surname>Chen</surname> <given-names>CH</given-names></name><name><surname>Hay</surname> <given-names>BA</given-names></name><name><surname>Hariharan</surname> <given-names>IK</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Inactivation of both foxo and reaper promotes long-term adult neurogenesis in <italic>Drosophila</italic></article-title><source>Current Biology</source><volume>20</volume><fpage>643</fpage><lpage>648</lpage><pub-id pub-id-type="doi">10.1016/j.cub.2010.01.060</pub-id><pub-id pub-id-type="pmid">20346676</pub-id></element-citation></ref><ref id="bib55"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Singh</surname> <given-names>SR</given-names></name><name><surname>Liu</surname> <given-names>Y</given-names></name><name><surname>Zhao</surname> <given-names>J</given-names></name><name><surname>Zeng</surname> <given-names>X</given-names></name><name><surname>Hou</surname> <given-names>SX</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>The novel tumour suppressor madm regulates stem cell competition in the <italic>Drosophila</italic> testis</article-title><source>Nature Communications</source><volume>7</volume><elocation-id>10473</elocation-id><pub-id pub-id-type="doi">10.1038/ncomms10473</pub-id><pub-id pub-id-type="pmid">26792023</pub-id></element-citation></ref><ref id="bib56"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Soga</surname> <given-names>T</given-names></name><name><surname>Ohashi</surname> <given-names>Y</given-names></name><name><surname>Ueno</surname> <given-names>Y</given-names></name><name><surname>Naraoka</surname> <given-names>H</given-names></name><name><surname>Tomita</surname> <given-names>M</given-names></name><name><surname>Nishioka</surname> <given-names>T</given-names></name></person-group><year iso-8601-date="2003">2003</year><article-title>Quantitative metabolome analysis using capillary electrophoresis mass spectrometry</article-title><source>Journal of Proteome Research</source><volume>2</volume><fpage>488</fpage><lpage>494</lpage><pub-id pub-id-type="doi">10.1021/pr034020m</pub-id><pub-id pub-id-type="pmid">14582645</pub-id></element-citation></ref><ref id="bib57"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Soga</surname> <given-names>T</given-names></name><name><surname>Baran</surname> <given-names>R</given-names></name><name><surname>Suematsu</surname> <given-names>M</given-names></name><name><surname>Ueno</surname> <given-names>Y</given-names></name><name><surname>Ikeda</surname> <given-names>S</given-names></name><name><surname>Sakurakawa</surname> <given-names>T</given-names></name><name><surname>Kakazu</surname> <given-names>Y</given-names></name><name><surname>Ishikawa</surname> <given-names>T</given-names></name><name><surname>Robert</surname> <given-names>M</given-names></name><name><surname>Nishioka</surname> <given-names>T</given-names></name><name><surname>Tomita</surname> <given-names>M</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>Differential metabolomics reveals ophthalmic acid as an oxidative stress biomarker indicating hepatic glutathione consumption*</article-title><source>Journal of Biological Chemistry</source><volume>281</volume><fpage>16768</fpage><lpage>16776</lpage><pub-id pub-id-type="doi">10.1074/jbc.M601876200</pub-id></element-citation></ref><ref id="bib58"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sousa-Victor</surname> <given-names>P</given-names></name><name><surname>Jasper</surname> <given-names>H</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Epithelial regeneration and Cancer: news from the src front</article-title><source>The EMBO Journal</source><volume>33</volume><fpage>1423</fpage><lpage>1424</lpage><pub-id pub-id-type="doi">10.15252/embj.201488815</pub-id><pub-id pub-id-type="pmid">24855224</pub-id></element-citation></ref><ref id="bib59"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stronach</surname> <given-names>B</given-names></name><name><surname>Perrimon</surname> <given-names>N</given-names></name></person-group><year iso-8601-date="2002">2002</year><article-title>Activation of the JNK pathway during dorsal closure in <italic>Drosophila</italic> requires the mixed lineage kinase, slipper</article-title><source>Genes &amp; Development</source><volume>16</volume><fpage>377</fpage><lpage>387</lpage><pub-id pub-id-type="doi">10.1101/gad.953002</pub-id><pub-id pub-id-type="pmid">11825878</pub-id></element-citation></ref><ref id="bib60"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Summy</surname> <given-names>JM</given-names></name><name><surname>Gallick</surname> <given-names>GE</given-names></name></person-group><year iso-8601-date="2003">2003</year><article-title>Src family kinases in tumor progression and metastasis</article-title><source>Cancer Metastasis Reviews</source><volume>22</volume><fpage>337</fpage><lpage>358</lpage><pub-id pub-id-type="doi">10.1023/a:1023772912750</pub-id><pub-id pub-id-type="pmid">12884910</pub-id></element-citation></ref><ref id="bib61"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tabata</surname> <given-names>S</given-names></name><name><surname>Yamamoto</surname> <given-names>M</given-names></name><name><surname>Goto</surname> <given-names>H</given-names></name><name><surname>Hirayama</surname> <given-names>A</given-names></name><name><surname>Ohishi</surname> <given-names>M</given-names></name><name><surname>Kuramoto</surname> <given-names>T</given-names></name><name><surname>Mitsuhashi</surname> <given-names>A</given-names></name><name><surname>Ikeda</surname> <given-names>R</given-names></name><name><surname>Haraguchi</surname> <given-names>M</given-names></name><name><surname>Kawahara</surname> <given-names>K</given-names></name><name><surname>Shinsato</surname> <given-names>Y</given-names></name><name><surname>Minami</surname> <given-names>K</given-names></name><name><surname>Saijo</surname> <given-names>A</given-names></name><name><surname>Hanibuchi</surname> <given-names>M</given-names></name><name><surname>Nishioka</surname> <given-names>Y</given-names></name><name><surname>Sone</surname> <given-names>S</given-names></name><name><surname>Esumi</surname> <given-names>H</given-names></name><name><surname>Tomita</surname> <given-names>M</given-names></name><name><surname>Soga</surname> <given-names>T</given-names></name><name><surname>Furukawa</surname> <given-names>T</given-names></name><name><surname>Akiyama</surname> <given-names>SI</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Thymidine catabolism as a metabolic strategy for Cancer survival</article-title><source>Cell Reports</source><volume>19</volume><fpage>1313</fpage><lpage>1321</lpage><pub-id pub-id-type="doi">10.1016/j.celrep.2017.04.061</pub-id><pub-id pub-id-type="pmid">28514652</pub-id></element-citation></ref><ref id="bib62"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Takahashi</surname> <given-names>F</given-names></name><name><surname>Endo</surname> <given-names>S</given-names></name><name><surname>Kojima</surname> <given-names>T</given-names></name><name><surname>Saigo</surname> <given-names>K</given-names></name></person-group><year iso-8601-date="1996">1996</year><article-title>Regulation of cell-cell contacts in developing <italic>Drosophila</italic> eyes by Dsrc41, a new, close relative of vertebrate c-src</article-title><source>Genes &amp; Development</source><volume>10</volume><fpage>1645</fpage><lpage>1656</lpage><pub-id pub-id-type="doi">10.1101/gad.10.13.1645</pub-id><pub-id pub-id-type="pmid">8682295</pub-id></element-citation></ref><ref id="bib63"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Takatsu</surname> <given-names>Y</given-names></name><name><surname>Nakamura</surname> <given-names>M</given-names></name><name><surname>Stapleton</surname> <given-names>M</given-names></name><name><surname>Danos</surname> <given-names>MC</given-names></name><name><surname>Matsumoto</surname> <given-names>K</given-names></name><name><surname>O'Connor</surname> <given-names>MB</given-names></name><name><surname>Shibuya</surname> <given-names>H</given-names></name><name><surname>Ueno</surname> <given-names>N</given-names></name></person-group><year iso-8601-date="2000">2000</year><article-title>TAK1 participates in c-Jun N-terminal kinase signaling during <italic>Drosophila</italic> development</article-title><source>Molecular and Cellular Biology</source><volume>20</volume><fpage>3015</fpage><lpage>3026</lpage><pub-id pub-id-type="doi">10.1128/MCB.20.9.3015-3026.2000</pub-id><pub-id pub-id-type="pmid">10757786</pub-id></element-citation></ref><ref id="bib64"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tateno</surname> <given-names>M</given-names></name><name><surname>Nishida</surname> <given-names>Y</given-names></name><name><surname>Adachi-Yamada</surname> <given-names>T</given-names></name></person-group><year iso-8601-date="2000">2000</year><article-title>Regulation of JNK by src <italic>during Drosophila</italic> development</article-title><source>Science</source><volume>287</volume><fpage>324</fpage><lpage>327</lpage><pub-id pub-id-type="doi">10.1126/science.287.5451.324</pub-id><pub-id pub-id-type="pmid">10634792</pub-id></element-citation></ref><ref id="bib65"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Terriente-Félix</surname> <given-names>A</given-names></name><name><surname>Pérez</surname> <given-names>L</given-names></name><name><surname>Bray</surname> <given-names>SJ</given-names></name><name><surname>Nebreda</surname> <given-names>AR</given-names></name><name><surname>Milán</surname> <given-names>M</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>A <italic>Drosophila</italic> model of myeloproliferative neoplasm reveals a feed-forward loop in the JAK pathway mediated by p38 MAPK signalling</article-title><source>Disease Models &amp; Mechanisms</source><volume>10</volume><fpage>399</fpage><lpage>407</lpage><pub-id pub-id-type="doi">10.1242/dmm.028118</pub-id><pub-id pub-id-type="pmid">28237966</pub-id></element-citation></ref><ref id="bib66"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vrailas-Mortimer</surname> <given-names>A</given-names></name><name><surname>del Rivero</surname> <given-names>T</given-names></name><name><surname>Mukherjee</surname> <given-names>S</given-names></name><name><surname>Nag</surname> <given-names>S</given-names></name><name><surname>Gaitanidis</surname> <given-names>A</given-names></name><name><surname>Kadas</surname> <given-names>D</given-names></name><name><surname>Consoulas</surname> <given-names>C</given-names></name><name><surname>Duttaroy</surname> <given-names>A</given-names></name><name><surname>Sanyal</surname> <given-names>S</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>A muscle-specific p38 MAPK/Mef2/MnSOD pathway regulates stress, motor function, and life span in <italic>Drosophila</italic></article-title><source>Developmental Cell</source><volume>21</volume><fpage>783</fpage><lpage>795</lpage><pub-id pub-id-type="doi">10.1016/j.devcel.2011.09.002</pub-id><pub-id pub-id-type="pmid">22014527</pub-id></element-citation></ref><ref id="bib67"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wassarman</surname> <given-names>DA</given-names></name><name><surname>Solomon</surname> <given-names>NM</given-names></name><name><surname>Rubin</surname> <given-names>GM</given-names></name></person-group><year iso-8601-date="1996">1996</year><article-title>Pk92b: <italic>a Drosophila melanogaster</italic> protein kinase that belongs to the mekk family</article-title><source>Gene</source><volume>169</volume><fpage>283</fpage><lpage>284</lpage><pub-id pub-id-type="doi">10.1016/0378-1119(95)00790-3</pub-id></element-citation></ref><ref id="bib68"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yeatman</surname> <given-names>TJ</given-names></name></person-group><year iso-8601-date="2004">2004</year><article-title>A renaissance for SRC</article-title><source>Nature Reviews Cancer</source><volume>4</volume><fpage>470</fpage><lpage>480</lpage><pub-id pub-id-type="doi">10.1038/nrc1366</pub-id><pub-id pub-id-type="pmid">15170449</pub-id></element-citation></ref><ref id="bib69"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yoo</surname> <given-names>SK</given-names></name><name><surname>Pascoe</surname> <given-names>HG</given-names></name><name><surname>Pereira</surname> <given-names>T</given-names></name><name><surname>Kondo</surname> <given-names>S</given-names></name><name><surname>Jacinto</surname> <given-names>A</given-names></name><name><surname>Zhang</surname> <given-names>X</given-names></name><name><surname>Hariharan</surname> <given-names>IK</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Plexins function in epithelial repair in both <italic>Drosophila</italic> and zebrafish</article-title><source>Nature Communications</source><volume>7</volume><elocation-id>12282</elocation-id><pub-id pub-id-type="doi">10.1038/ncomms12282</pub-id><pub-id pub-id-type="pmid">27452696</pub-id></element-citation></ref></ref-list></back><sub-article article-type="decision-letter" id="sa1"><front-stub><article-id pub-id-type="doi">10.7554/eLife.59809.sa1</article-id><title-group><article-title>Decision letter</article-title></title-group><contrib-group><contrib contrib-type="editor"><name><surname>Banerjee</surname><given-names>Utpal</given-names></name><role>Reviewing Editor</role><aff><institution>University of California, Los Angeles</institution><country>United States</country></aff></contrib></contrib-group></front-stub><body><boxed-text><p>In the interests of transparency, eLife publishes the most substantive revision requests and the accompanying author responses.</p></boxed-text><p><bold>Acceptance summary:</bold></p><p>In this manuscript, the authors address some of the most critical issues regarding the function of upstream components of JNK signaling that have lingered around, unsolved, for quite some time. Although it was known that a key activation point was at the level of a KKKinase, which was almost certain to be slipper, the question of how this pathway controls multiple functions including the apparently contradictory phenotypes of proliferation and cell death has been worked out in some detail in this paper and the study opens, as well, doors for further analysis of how a cell keeps information channelized while also allowing for the possibility of cross talk that maintain homeostatic balance.</p><p><bold>Decision letter after peer review:</bold></p><p>Thank you for submitting your article &quot;Methionine restriction breaks obligatory coupling of cell proliferation and death by an oncogene Src in <italic>Drosophila</italic>&quot; for consideration by <italic>eLife</italic>. Your article has been reviewed by 3 peer reviewers, one of whom is a member of our Board of Reviewing Editors, and the evaluation has been overseen by Utpal Banerjee as the Senior Editor. The reviewers have opted to remain anonymous.</p><p>The reviewers have discussed the reviews with one another and the Reviewing Editor has drafted this decision to help you prepare a revised submission. Normally, we summarize the reviews at this point to list the specific list of experiments that we expect the authors to conduct. Given the difficulties these days with performing extensive experiments, we provide you with the full reviews so that you can determine the critical issues on which you should focus when carrying out revisions. You will see that the src-slpr aspect is universally lauded as novel. The issues raised have to do with the methionine/TOR angle. It should be easy to determine from the reviews the aspects that are most important to the reviewers. Some parts are easily addressed. If you so wish, please feel free to let us know if there is some aspect that might be particularly difficult to handle experimentally, and I will run this by the reviewers. Please also note the following <italic>eLife</italic> policy:</p><p>The editors have judged that your manuscript is of interest to <italic>eLife</italic>, but as described below additional experiments are required before it is published. We would like to draw your attention to changes in our revision policy that we have made in response to COVID-19 (<ext-link ext-link-type="uri" xlink:href="https://elifesciences.org/articles/57162">https://elifesciences.org/articles/57162</ext-link>).</p><p>First, because many researchers have temporarily lost access to the labs, we will give authors as much time as they need to submit revised manuscripts. We are also offering, if you choose, to post the manuscript to bioRxiv (if it is not already there) along with this decision letter and a formal designation that the manuscript is &quot;in revision at <italic>eLife</italic>&quot;. Please let us know if you would like to pursue this option. (If your work is more suitable for medRxiv, you will need to post the preprint yourself, as the mechanisms for us to do so are still in development.)</p><p>Summary:</p><p>This study by Nishida et al. investigates the mechanisms by which the well-known phenomenon of constitutive activation of Src mediates both cell growth and apoptosis during tumorigenesis. In particular, the authors sought to explore whether these two pathways were coupled and through what downstream effectors Src functions. They found that indeed both cell growth and apoptosis were obligately coupled through the &quot;lynchpin&quot; protein Slpr, which mediates cell growth through a Src-p38-Tor pathway and apoptosis through a Src-JNK pathway.</p><p><italic>Reviewer #1:</italic></p><p>Overall, the authors the authors do a good job rationalizing, designing, explaining, and interpreting most of their results and the important contributions and insights of this paper in both identifying that Src mediates JNK activity, which was not previously understood well, and that it does this through through slpr provide important knowledge to the field. Although the genetic experiments are straightforward, the link with TOR and nutrition in interpreting the phenotype is more complex and difficult to explain as written.</p><p>1. The mechanistic link between Src-Slpr-p38 and TOR is not well developed. Although it is clear that TOR inhibition inhibits overgrowth, these experiments do not provide strong support for TOR being a bona fide component of the Src-Slpr-p38 axis. For example, loss of function of TOR is expected to have rather pleiotropic effects. Stronger mechanistic evidence of how p38 activates TOR, would greatly strengthen this line of reasoning. Currently, less direct mechanisms cannot be excluded.</p><p>2. The link between the genetic experiments and nutrition, for example the role of methionine, is quite interesting, but is not so well developed and the reasoning behind the experiments is difficult to follow. It seems as though the logic is that diluting amino acids decreases the tumor growth, and that adding the amino acids back suppresses the rescue. Addition of amino acid, without methionine, limits tumor growth to a degree and increases survival compared to EAAs, though the magnitude of the rescue is difficult to interpret (e.g. 7.5 % vs 15 % survival, with quite large variance). Adding methionine alone clearly limits survival of flies with tumor, though it is not clear that block is caused by TOR alone. These latter metabolic experiments are fairly difficult to interpret, and the link between Src-Slpr-p38 and TOR and methionine is not as clear as the work presented earlier in the paper.</p><p>3. Are there regional differences within the wing disc (Figure 1) where proliferation (pouch) vs apoptosis (edges) observed more commonly? How would such a difference fit into the model? Clonal analysis could shed light on this issue of autonomy</p><p><italic>Reviewer #2:</italic></p><p>In this paper, Nishida et al. address a long-standing and intensely-investigated question, namely how are cell proliferation and cell death controlled to modulate tissue growth in animals. They specifically investigate the effects of Src overexpression in imaginal tissues (which leads to both increases cell proliferation and cell death) and they make two key observations: (a) they identify the kinase Slpr as an effector of Src in the control of both cell proliferation (via p38) and cell death (via JNK); (b) they show that the effects of p38 are mediated via p38 and that dietary methionine can control TOR and modulate Src-mediated cell proliferation.</p><p>Overall, I liked this paper. I think the two main findings will be of interest to, not just <italic>Drosophila</italic> researchers, but also cell, developmental and cancer biologists interested in the regulation of tissue growth.</p><p>I have two main comments/questions:</p><p>1. Are the effects on cell proliferation and cell death strictly autonomous? It's hard to tell clearly from Figure 1, especially since the choice of driver of vg-Gal4 doesn't have clearly demarcated expression boundaries (compared to, say, en-GAL4 or ap-GAL4). This is import since, if the proliferation is a result of cell-death induced compensatory proliferation, then the interpretations of the data in the paper would be very different than if everything was strictly autonomous.</p><p>2. The link between p38 and TOR is interesting, but it relies on using measurement of phospho-4EBP as a readout of TOR signaling. These data are certainly very clean, however, it’s important to note that total levels of 4EPB are often induced upon stress signaling. Hence, it's important to be sure that the increase in phospho-4EBP signal does reflect an increase in the amounts of phosphorylated 4EBP (a TOR effect) vs simply an increase in total 4EBP (a TOR-independent, stress effect). A recent paper from the Karpac lab (Cell Reports, 2020) had some nice immunostaining with a non-phospho 4EBP, which would be a useful control in this manuscript. Alternatively, the induction of TOR could be confirmed with a phospho-S6k or phospho-S6 antibody (western on discs or immunostaining). The genetic expts with TOR certainly support a role for TOR in modulating Src function, but they could equally be interpreted as TOR signaling being a parallel pathway or TOR being a downstream Src pathway.</p><p><italic>Reviewer #3:</italic></p><p>The authors examine how an oncogene, Src, can activate both proliferation and apoptosis during oncogenesis. The answer is surprisingly simple. In the case of Src, it activates both pro-apoptotic (JNK) and proliferative (p38) MAPK pathways and upstream of this, the authors identify the MPKKK slpr as the lynchpin in this pathway. Src also activates Erk-type MAPK, but according to the authors, this has no effect for tumorigenesis. The authors then focus on the role of p38 and found that p38 controls Tor signaling. Interestingly, the nutrition status does influence Src-induced Tor signaling and tissue growth. To further delineate this observation, the authors tested each amino acid and found specifically a requirement of Methionine for Src-induced tumor growth. They also observed that the Methionine concentration in the hemolymph of these Src-bearing larvae is lower compared to controls, presumably because the Src-tumor tissue absorbs more of it. Overall, the authors present a model that combines several signaling pathways and metabolism for Src-induced tumor growth.</p><p>This is an interesting manuscript, but I do have some comments and suggestions for improvement.</p><p>1. What is the nature of Src42A CA? How does it promote dominant activity to Src?</p><p>2. Provide a complete picture of the Src CA suppressor screen in which they found slpr. Were there other suppressors and if so, why did they focus on slpr?</p><p>3. Present the results from the screen of the other MPKKK. Did they also screen the MPKK and other upstream components in the MPK pathway (Msn, Traf1, Traf2, Rho1)? This might tell us how Src activates Slpr.</p><p>4. How does Src activate Slpr? Is any of the domains of Slpr (SH2, SH3, kinase) required for this activation?</p><p>5. How many different slpr RNAi lines were tested? Are the results verified with several independent lines? Do slpr mutants suppress Src42ACA?</p><p>6. Verify the Erk-MAPK (rl) RNAi line(s).</p><p>7. The data presentation needs improvement. The discs are too small and often the relevant staining (PH3, cDcp1, TRE-RFP, etc.) is hard to judge. This is also particularly important for the non-cell autonomy of Erk and p38 activity in Figure 4A-B. Some convincing close-up pictures could help.</p><p>8. There is no comprehensive description of how the quantitation of the staining was conducted. Was the quantitation done in the region of overgrowth? How was the volume of GFP+ tissue determined? Were equivalently sized regions used and how was their level of fluorescence assessed? Was there some internal control to normalize for differences in general staining between regions of interest and region where no change would be expected (ie a part of the disc outside of the vg-Gal4 area)?</p><p>9. Figure 1A: quantify the cDcp1 staining.</p><p>10. Figure 2C: slpr RNAi seems to suppress TRE-RFP, but not overgrowth. In fact, the slpr RNAi disc (lower panels) is significantly larger than the src42ACA disc (middle panels) including the GFP+ area. That is inconsistent with the authors model. Explain. Please quantify GFP+ areas and overall disc size.</p><p>11. Figure 3B: Perform PH3 labeling in vg&gt;Src42ACA JNKDN slprRNAi background. I would like to know if the overgrowth and PH3 labeling in Src42ACA JNKDN is dependent on Slpr. The authors imply this, but don't show it.</p><p>12. Figure 5A-B: is the 4EBP phosphorylation in vg&gt;Src42CA JNK DN discs depended on Slpr, i.e. does slpr RNAi block it?</p><p>13. In the Discussion, the authors mention that &quot;methionine regulates Tor activation&quot;. I don't think this direct link was established in this paper.</p><p>14. Is the a SAMTOR homolog in flies? If so, test it in the Src42ACA screen.</p></body></sub-article><sub-article article-type="reply" id="sa2"><front-stub><article-id pub-id-type="doi">10.7554/eLife.59809.sa2</article-id><title-group><article-title>Author response</article-title></title-group></front-stub><body><disp-quote content-type="editor-comment"><p>Reviewer #1:</p><p>Overall, the authors the authors do a good job rationalizing, designing, explaining, and interpreting most of their results and the important contributions and insights of this paper in both identifying that Src mediates JNK activity, which was not previously understood well, and that it does this through through slpr provide important knowledge to the field. Although the genetic experiments are straightforward, the link with TOR and nutrition in interpreting the phenotype is more complex and difficult to explain as written.</p><p>1. The mechanistic link between Src-Slpr-p38 and TOR is not well developed. Although it is clear that TOR inhibition inhibits overgrowth, these experiments do not provide strong support for TOR being a bona fide component of the Src-Slpr-p38 axis. For example, loss of function of TOR is expected to have rather pleiotropic effects. Stronger mechanistic evidence of how p38 activates TOR, would greatly strengthen this line of reasoning. Currently, less direct mechanisms cannot be excluded.</p></disp-quote><p>In the original manuscript, we had three pieces of data related to Tor signaling.</p><p>1. Src-p38 activates Tor signaling, based on p4EBP.</p><p>2. Tor inhibition suppresses Src-induced tumorigenesis.</p><p>3. Methionine is important for Tor signaling and Src-induced tumorigenesis.</p><p>Based on 1 and 2, we feel it was reasonable to describe that Src-p38-Tor signaling regulates Src-induced tumorigenesis. What was not clear was how Src-p38-Tor signaling crosstalks with methionine-Tor signaling and also how Src-p38 regulates Tor. The link between methionine and Tor was not strong either. As the reviewers see below, we spent considerable time and effort to address these points in this revision. What we eventually elucidated is a rather complicated mechanism, but at least it provides a clearer picture of what’s occurring during Src oncogenesis. The following is what we found.</p><p>Regarding methionine-Tor signaling, we found that Sam synthetase, which makes a methyl donor SAM from methionine, is important for Tor activation and Src-induced tumorigenesis (Figure 7 I-K). We also found that Samtor, a Sam sensor that regulates Tor, is important for Src-induced Tor regulation (Figure 7—figure supplement 2 D-F). These findings strengthen the link between methionine and Tor during Src-mediated oncogenesis.</p><p>Regarding how Src regulates methionine-Tor signaling, we found that Src promotes uptake of methionine in the tumor and also conversion of methionine to SAM (methionine flux) (Figure 8A-C). However, this was independent of p38 (Figure 8D-F). This indicates that Src could potentially activate methionine-Tor signaling through activation of methionine metabolism (uptake and flux) in a p38-independent manner.</p><p>So, a question is how Src-p38 contributes to Tor activation, since clearly Src-p38 signaling activates Tor (Figure 5A-B). Although previously it was shown that p38 activates Tor, its mechanism was not clear <sup>1</sup>. To address this point sincerely, we started a new collaboration with Dr Diana Ho at Harvard, who previously performed RNAseq of the <italic>vg&gt;Src42A CA</italic> wing disc <sup>2</sup>. We surveyed expression levels of potential Tor regulators and selected genes that are affected by <italic>Src</italic> expression, including amino acid transporters and GATOR complexes. GATOR complexes regulate Tor through Rag GTPases <sup>3,4</sup>. We examined whether their expression is regulated by Src in a p38-dpendent manner using RT-qPCR. We found that among the amino acid transporters and GATOR complex components examined, only <italic>pathetic</italic> (<italic>path</italic>), a SLC36 amino acid transporter that can transport multiple amino acids, was significantly induced by Src in a p38-dependent manner (Figure 8—figure supplement 1D-E). Since Path can mediate amino acids-mediated Tor activation <sup>5,6</sup>, we speculate that Src-p38 could regulate Tor potentially through Path-mediated uptake of non-methionine amino acids.</p><p>We acknowledge that our data on Path’s role during Src tumorigenesis are indirect and at best suggestive, so we included the data of Path in discussion and carefully discussed this possible mechanism in the manuscript.</p><p>Our findings on the role for Src-p38 signaling in Tor activation is consistent with the previous findings that p38 is necessary for Tor activation in response to amino acids <sup>1</sup>. Our suggestion of the role for non-methionine amino acids in Tor regulation, at a glance, may seem contradictory from our amino acid subtraction data, which showed that only subtraction of methionine could affect survival over the Src tumor (Figure 7B). But we speculate that because of Path’s function to uptake multiple amino acids, which provides redundancy, single amino acid subtraction experiments elucidated only the function of methionine. In a future study, it will be interesting to investigate effects of subtracting multiple amino acids at the same time.</p><p>Here we’d like to emphasize and clarify that the original purpose of this paper was to find the mechanism by which Src induces both cell death and proliferation. But somehow, while we explore the mechanism of Src-mediated Tor regulation and proliferation during revision, this part became unexpectedly and unbalancingly huge. But, we still feel that our original, simple schematic that explains the mechanism of cell death/proliferation is valid (Figure 8G). In this revised manuscript, we also included a schematic showing a detailed possible mechanism by which Src regulates methionine-Tor signaling (Figure 8—figure supplement 1F).</p><disp-quote content-type="editor-comment"><p>2. The link between the genetic experiments and nutrition, for example the role of methionine, is quite interesting, but is not so well developed and the reasoning behind the experiments is difficult to follow. It seems as though the logic is that diluting amino acids decreases the tumor growth, and that adding the amino acids back suppresses the rescue. Addition of amino acid, without methionine, limits tumor growth to a degree and increases survival compared to EAAs, though the magnitude of the rescue is difficult to interpret (e.g. 7.5 % vs 15 % survival, with quite large variance). Adding methionine alone clearly limits survival of flies with tumor, though it is not clear that block is caused by TOR alone. These latter metabolic experiments are fairly difficult to interpret, and the link between Src-Slpr-p38 and TOR and methionine is not as clear as the work presented earlier in the paper.</p></disp-quote><p>Regarding the link between the genetic experiments and nutrition manipulation, please see the response above.</p><p>Regarding the variance of the survival rate, we feel it’s an intrinsic property of physiological experiments like ours. Because of the variance in these physiological experiments, we adopted valid statistical analyses. All information of the statistical analyses were included in table 3.</p><disp-quote content-type="editor-comment"><p>3. Are there regional differences within the wing disc (Figure 1) where proliferation (pouch) vs apoptosis (edges) observed more commonly? How would such a difference fit into the model? Clonal analysis could shed light on this issue of autonomy</p></disp-quote><p>Let us clarify where apoptosis and proliferation occur. We quantified both autonomous and non-autonomous proliferation/death in this revised manuscript (Figure 1B, 1D and Figure 4—figure supplement 1D, 1G).</p><p>Regarding cell death, it’s almost exclusively cell autonomous, with a slight non-cell autonomous effect, which is consistent with the similar JNK activation pattern (Figure 2C). On the other hand, Src provokes cell proliferation both autonomously and non- autonomously, which is consistent with the similar p38 activation pattern (Figure 4A). We presume why pH3 looked more dominant in the pouch for the reviewer is likely because there are high, basal background signals of pH3 outside of the <italic>vg-gal4</italic> region while cell death is relatively restrictive to the <italic>vg-gal4</italic> region without basal background signals.</p><p>One thing we noticed during experimentation is that when we induced massive overgrowth by combining Src activation and JNK inhibition, the massive growth always occurs at the “side” region. We speculate that this “side region” may correspond to the previously identified “hot spots” <sup>7</sup></p><p>Regarding the clonal analysis, Src clone cells induce strong cell competition <sup>8</sup> and clonal analyses are intrinsically unreproducible and unpredictable, thus in this study we mainly stick to <italic>vg-gal4</italic>. This approach with <italic>vg-gal4</italic> and <italic>UAS-Src42A CA</italic> has been previously adopted by the group of Spyros Artavanis-Tsakonas <sup>2</sup>.</p><disp-quote content-type="editor-comment"><p>Reviewer #2:</p><p>In this paper, Nishida et al. address a long-standing and intensely-investigated question, namely how are cell proliferation and cell death controlled to modulate tissue growth in animals. They specifically investigate the effects of Src overexpression in imaginal tissues (which leads to both increases cell proliferation and cell death) and they make two key observations: (a) they identify the kinase Slpr as an effector of Src in the control of both cell proliferation (via p38) and cell death (via JNK), (b) they show that the effects of p38 are mediated via p38 and that dietary methionine can control TOR and modulate Src-mediated cell proliferation.</p><p>Overall, I liked this paper. I think the two main findings will be of interest to, not just <italic>Drosophila</italic> researchers, but also cell, developmental and cancer biologists interested in the regulation of tissue growth.</p><p>I have two main comments/questions:</p><p>1. Are the effects on cell proliferation and cell death strictly autonomous? It's hard to tell clearly from Figure 1, especially since the choice of driver of vg-Gal4 doesn't have clearly demarcated expression boundaries (compared to, say, en-GAL4 or ap-GAL4). This is import since, if the proliferation is a result of cell-death induced compensatory proliferation, then the interpretations of the data in the paper would be very different than if everything was strictly autonomous.</p></disp-quote><p>This has an overlap with the reviewer 1’s comment (Major point 3).</p><p>In brief, Src induces cell death and proliferation both cell autonomously and non-cell autonomously. But, cell death is more cell autonomous while cell proliferation is rather both autonomous and non-autonomous. In this paper, we almost exclusively focused on the cell autonomous phenotype and manipulated genes autonomously.</p><p>The reviewer is speculating that non-autonomous cell death may lead to more autonomous cell proliferation due to compensatory proliferation. Theoretically that is possible, but we think it is unlikely because of the following reason. We quantified the effect of <italic>slpr</italic> RNAi to non-cell autonomous JNK activation and cell death. s<italic>lpr</italic> knockdown does not affect JNK or cell death non autonomously (Figure 4—figure supplement 1E-G) but affects cell autonomous proliferation (Figure 3A-D). this strongly suggests cell autonomous proliferation is due to the autonomous signaling events, not due to non-cell autonomous cell death.</p><p>We would also like to note that the boundary of <italic>vg-gal4</italic> is relatively clear in a normal situation, but <italic>Src</italic> expression makes the expression boundary less clear likely due to cell death. According to literature, this Src-induced hazy boundary seems to occur even with clonal analyses <sup>8</sup> or another gal4 driver such as <italic>ptc-gal4</italic><sup>10</sup>.</p><disp-quote content-type="editor-comment"><p>2. The link between p38 and TOR is interesting, but it relies on using measurement of phospho-4EBP as a readout of TOR signaling. These data are certainly very clean, however, it’s important to note that total levels of 4EPB are often induced upon stress signaling. Hence, it's important to be sure that the increase in phospho-4EBP signal does reflect an increase in the amounts of phosphorylated 4EBP (a TOR effect) vs simply an increase in total 4EBP (a TOR-independent, stress effect). A recent paper from the Karpac lab (Cell Reports, 2020) had some nice immunostaining with a non-phospho 4EBP, which would be a useful control in this manuscript. Alternatively, the induction of TOR could be confirmed with a phospho-S6k or phospho-S6 antibody (western on discs or immunostaining). The genetic expts with TOR certainly support a role for TOR in modulating Src function, but they could equally be interpreted as TOR signaling being a parallel pathway or TOR being a downstream Src pathway.</p></disp-quote><p>We thank this reviewer for this useful comment. By striking a new collaboration with Dr Jongkyeong Chung, we included data of pS6. Src induces phosphorylation of S6 in addition to p4EBP(Figure 5—figure supplement 1B-C).</p><disp-quote content-type="editor-comment"><p>Reviewer #3:</p><p>The authors examine how an oncogene, Src, can activate both proliferation and apoptosis during oncogenesis. The answer is surprisingly simple. In the case of Src, it activates both pro-apoptotic (JNK) and proliferative (p38) MAPK pathways and upstream of this, the authors identify the MPKKK slpr as the lynchpin in this pathway. Src also activates Erk-type MAPK, but according to the authors, this has no effect for tumorigenesis. The authors then focus on the role of p38 and found that p38 controls Tor signaling. Interestingly, the nutrition status does influence Src-induced Tor signaling and tissue growth. To further delineate this observation, the authors tested each amino acid and found specifically a requirement of Methionine for Src-induced tumor growth. They also observed that the Methionine concentration in the hemolymph of these Src-bearing larvae is lower compared to controls, presumably because the Src-tumor tissue absorbs more of it. Overall, the authors present a model that combines several signaling pathways and metabolism for Src-induced tumor growth.</p><p>This is an interesting manuscript, but I do have some comments and suggestions for improvement.</p><p>1. What is the nature of Src42A CA? How does it promote dominant activity to Src?</p></disp-quote><p>We failed to provide sufficient explanation. We apologize for this. We specified Src 42A CA is “<italic>Src42A</italic> with an amino acid substitution of Tyr<sup>511</sup> to Phe , which is refractory to inactivating phosphorylation by Csk <sup>11</sup>” in text.</p><disp-quote content-type="editor-comment"><p>2. Provide a complete picture of the Src CA suppressor screen in which they found slpr. Were there other suppressors and if so, why did they focus on slpr?</p></disp-quote><p>Our original screen focused on factors related to cell death, trying to find a mediator of Src-induced cell death. We included a list of RNAis we used (Figure 2—figure supplement 1A-B, table 1). Among RNAis we checked, only <italic>slpr</italic> RNAi demonstrated both high survival and recovered wings. Some of other RNAis enhanced survival but not the wing phenotype (Figure 2—figure supplement 1A-B), suggesting these should affect non-tissue autonomous event.</p><disp-quote content-type="editor-comment"><p>3. Present the results from the screen of the other MPKKK. Did they also screen the MPKK and other upstream components in the MPK pathway (Msn, Traf1, Traf2, Rho1)? This might tell us how Src activates Slpr.</p></disp-quote><p>At least, based on the survival assay, other JNKKK (dTAK1, Mekk1, Ask1, Wnd) were not hits. Msn, traf1, Traf2, msn or Rho1 were not positive hits either. But again, we’d like to emphasize a caveat of negative data in RNAi screening due to low efficiency of knockdown.</p><disp-quote content-type="editor-comment"><p>4. How does Src activate Slpr? Is any of the domains of Slpr (SH2, SH3, kinase) required for this activation?</p></disp-quote><p>This is related to the point 3 above. Among the potential mediators of Src-Slpr signaling, we found that inhibition of Shark, which is a non-receptor tyrosine kinase of the syk family, could suppress the wing phenotype by Src (<xref ref-type="fig" rid="respfig1">Author response image 1</xref>). Shark could potentially function downstream of Src <sup>12</sup> To solidify and expand a story on Shark, we feel it’ll require much more experimentation. Importance of each domain of Slpr has been extensively investigated previously <sup>13,14</sup>, and we did not focus on these domains in this study. We acknowledge that to clarify what mediates Src-Slpr signaling and which domain of Slpr is involved in the process could be an important future question.</p><fig id="respfig1"><label>Author response image 1.</label><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-59809-resp-fig1-v1.tif"/></fig><disp-quote content-type="editor-comment"><p>5. How many different slpr RNAi lines were tested? Are the results verified with several independent lines? Do slpr mutants suppress Src42ACA?</p></disp-quote><p>We used two RNAis (Figure 2 and Figure 3—figure supplement 1A-D). We also checked knockdown efficiency of both RNAis by RT-qPCR (Figure 2—figure supplement 1C and Figure 3—figure supplement 1D). Slpr mutant is homozygous lethal, thus we decided not to use it in this manuscript.</p><disp-quote content-type="editor-comment"><p>6. Verify the Erk-MAPK (rl) RNAi line(s).</p></disp-quote><p>The <italic>erk</italic> RNAis we used had been previously validated (Singh, Liu, Zhao, Zeng, &amp; Hou, 2016). Erk inhibition does not suppress proliferation (Fig 4-figure supplement 1I), which is in a clear contrast to p38 inhibition. We also verified an efficiency of an <italic>erk</italic> RNAi using the rough eye phenotype induced by Ras activation (Fig4-figure supplement 1J). To the best of our knowledge, there has been no Erk DN generated in <italic>Drosophila</italic>.</p><disp-quote content-type="editor-comment"><p>7. The data presentation needs improvement. The discs are too small and often the relevant staining (PH3, cDcp1, TRE-RFP, etc.) is hard to judge. This is also particularly important for the non-cell autonomy of Erk and p38 activity in Figure 4A-B. Some convincing close-up pictures could help.</p></disp-quote><p>We included magnified pictures in the revised manuscript. We also included quantification of almost all data.</p><disp-quote content-type="editor-comment"><p>8. There is no comprehensive description of how the quantitation of the staining was conducted. Was the quantitation done in the region of overgrowth? How was the volume of GFP+ tissue determined? Were equivalently sized regions used and how was their level of fluorescence assessed? Was there some internal control to normalize for differences in general staining between regions of interest and region where no change would be expected (ie a part of the disc outside of the vg-Gal4 area)?</p></disp-quote><p>We included this information in the method section.</p><disp-quote content-type="editor-comment"><p>9. Figure 1A: quantify the cDcp1 staining.</p></disp-quote><p>We quantified the data as requested (Figure 1D).</p><disp-quote content-type="editor-comment"><p>10. Figure 2C: slpr RNAi seems to suppress TRE-RFP, but not overgrowth. In fact, the slpr RNAi disc (lower panels) is significantly larger than the src42ACA disc (middle panels) including the GFP+ area. That is inconsistent with the authors model. Explain. Please quantify GFP+ areas and overall disc size.</p></disp-quote><p>As the reviewer rightfully noticed, <italic>slpr</italic> RNAi suppresses TRE-RFP, that is, cell death. Because of the suppression of cell death, <italic>slpr</italic> RNAi makes discs bigger than the Src42A CA disc, where death continuously occurs. Compared to the real overgrowth phenotype by Src activation and JNK inhibition, the effect of <italic>slpr</italic> RNAi to Src disc is much milder because it suppresses both cell death and proliferation. We quantified all data as requested.</p><disp-quote content-type="editor-comment"><p>11. Figure 3B: Perform PH3 labeling in vg&gt;Src42ACA JNKDN slprRNAi background. I would like to know if the overgrowth and PH3 labeling in Src42ACA JNKDN is dependent on Slpr. The authors imply this, but don't show it.</p></disp-quote><p>We performed this experiment as requested (Figure 3—figure supplement 1G-I).</p><disp-quote content-type="editor-comment"><p>12. Figure 5A-B: is the 4EBP phosphorylation in vg&gt;Src42CA JNK DN discs depended on Slpr, i.e. does slpr RNAi block it?</p></disp-quote><p>We now included data showing that <italic>slpr</italic> RNAi blocks S6 phosphorylation in <italic>vg&gt;src42A CA, JNK DN</italic> discs (Figure 5—figure supplement 1B-C).</p><disp-quote content-type="editor-comment"><p>13. In the Discussion, the authors mention that &quot;methionine regulates Tor activation&quot;. I don't think this direct link was established in this paper.</p></disp-quote><p>We mainly focused on this point in this revision. Please see the response to the reviewer 1.</p><disp-quote content-type="editor-comment"><p>14. Is the a SAMTOR homolog in flies? If so, test it in the Src42ACA screen.</p></disp-quote><p>Yes. The paper by the Sabatini lab demonstrated that SAMTOR works in the fly cells <sup>15</sup>. In this revised manuscript, we inhibited samtor. As expected, it enhanced tor (Figure 7—figure supplement 2D-F), but puzzlingly it suppressed proliferation. We speculate that this growth suppression is likely attributed to Samtor’s predicted methyltransferase function, which may not be related to Tor signaling.</p><p>References:</p><p>1 Cully, M. <italic>et al.</italic> A role for p38 stress-activated protein kinase in regulation of cell growth via TORC1. <italic>Mol Cell Biol</italic> 30, 481-495, doi:10.1128/MCB.00688-09 (2010).</p><p>2 Ho, D. M., Pallavi, S. K. and Artavanis-Tsakonas, S. The Notch-mediated hyperplasia circuitry in <italic>Drosophila</italic> reveals a Src-JNK signaling axis. <italic>eLife</italic> 4, e05996, doi:10.7554/<italic>eLife</italic>.05996 (2015).</p><p>3 Kim, J. and Guan, K. L. mTOR as a central hub of nutrient signalling and cell growth. <italic>Nat Cell Biol</italic> 21, 63-71, doi:10.1038/s41556-018-0205-1 (2019).</p><p>4 Sabatini, D. M. Twenty-five years of mTOR: Uncovering the link from nutrients to growth. <italic>Proc Natl Acad Sci U S A</italic> 114, 11818-11825, doi:10.1073/pnas.1716173114 (2017).</p><p>5 Newton, H. <italic>et al.</italic> Systemic muscle wasting and coordinated tumour response drive tumourigenesis. <italic>Nat Commun</italic> 11, 4653, doi:10.1038/s41467-020-18502-9 (2020).</p><p>6 Goberdhan, D. C., Meredith, D., Boyd, C. A. and Wilson, C. PAT-related amino acid transporters regulate growth via a novel mechanism that does not require bulk transport of amino acids. <italic>Development</italic> 132, 2365-2375, doi:10.1242/dev.01821 (2005).</p><p>7 Tamori, Y., Suzuki, E. and Deng, W. M. Epithelial Tumors Originate in Tumor Hotspots, a Tissue-Intrinsic Microenvironment. <italic>PLoS Biol</italic> 14, e1002537, doi:10.1371/journal.pbio.1002537 (2016).</p><p>8 Enomoto, M. and Igaki, T. Src controls tumorigenesis via JNK-dependent regulation of the Hippo pathway in <italic>Drosophila</italic>. <italic>EMBO Rep</italic> 14, 65-72, doi:10.1038/embor.2012.185 (2013).</p><p>9 Singh, S. R., Liu, Y., Zhao, J., Zeng, X. and Hou, S. X. The novel tumour suppressor Madm regulates stem cell competition in the <italic>Drosophila</italic> testis. <italic>Nat Commun</italic> 7, 10473, doi:10.1038/ncomms10473 (2016).</p><p>10 Vidal, M., Larson, D. E. and Cagan, R. L. Csk-deficient boundary cells are eliminated from normal <italic>Drosophila</italic> epithelia by exclusion, migration, and apoptosis. <italic>Dev Cell</italic> 10, 33-44, doi:10.1016/j.devcel.2005.11.007 (2006).</p><p>11 Tateno, M., Nishida, Y. and Adachi-Yamada, T. Regulation of JNK by Src during <italic>Drosophila</italic> development. <italic>Science</italic> 287, 324-327, doi:10.1126/science.287.5451.324 (2000).</p><p>12 Biswas, R., Stein, D. and Stanley, E. R. <italic>Drosophila</italic> Dok is required for embryonic dorsal closure. <italic>Development</italic> 133, 217-227, doi:10.1242/dev.02198 (2006).</p><p>13 Garlena, R. A., Gonda, R. L., Green, A. B., Pileggi, R. M. and Stronach, B. Regulation of mixed-lineage kinase activation in JNK-dependent morphogenesis. <italic>J Cell Sci</italic> 123, 3177-3188, doi:10.1242/jcs.063313 (2010).</p><p>14 Neisch, A. L., Speck, O., Stronach, B. and Fehon, R. G. Rho1 regulates apoptosis via activation of the JNK signaling pathway at the plasma membrane. <italic>J Cell Biol</italic> 189, 311-323, doi:10.1083/jcb.200912010 (2010).</p><p>15 Gu, X. <italic>et al.</italic> SAMTOR is an S-adenosylmethionine sensor for the mTORC1 pathway. <italic>Science</italic> 358, 813-818, doi:10.1126/science.aao3265 (2017).</p></body></sub-article></article>